FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Lip

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Ming-Liang Zuo; Hung-Fat Tse; Koon-Ho Chan; Yap-Hang Chan; Boon-Hor Chong; Kwok-Fai Lam; Chu-Pak Lau; Kui-Kai Lau; Yuk-Fai Lau; Gregory Y H Lip; Shasha Liu; Chung Wah SIU
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.
Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.
Amitava Banerjee; Laurent Fauchier; Jean Michel Halimi; Sophie Taillandier; Patrick Vourc'h; Christian R Andres; Gregory Y H Lip
Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the loire valley atrial fibrillation project.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Lip (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ming-Liang Zuo; Hung-Fat Tse; Koon-Ho Chan; Yap-Hang Chan; Boon-Hor Chong; Kwok-Fai Lam; Chu-Pak Lau; Kui-Kai Lau; Yuk-Fai Lau; Gregory Y H Lip; Shasha Liu; Chung Wah SIU
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2013;37(1):47-54.
2013: Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.
Journal of cardiovascular translational research 2013;6(3):388-97.
2013: Amitava Banerjee; Laurent Fauchier; Jean Michel Halimi; Sophie Taillandier; Patrick Vourc'h; Christian R Andres; Gregory Y H Lip
Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the loire valley atrial fibrillation project.
Journal of the American College of Cardiology 2013;61(20):2079-87.
2013: Ahmed M Adlan; Paul J Fadel; Gregory Y H Lip; James P Fisher
Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure.
International journal of cardiology 2013;165(2):e15-7.
2013: Deirdre A Lane; Gregory Y H Lip
Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients?
Nature reviews. Cardiology 2013;10(5):241-2.
2013: Gregory Y H Lip
Awareness and treatment of atrial fibrillation in older adults: the present and the future.
QJM : monthly journal of the Association of Physicians 2013;106(5):393-4.
2013: Ida Ehlers Albertsen; Tina Graungaard; Torben Bjerregaard Larsen; Thure Filskov Overvad; Lars Hvilsted Rasmussen; Gregory Y H Lip
Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis.
Stroke; a journal of cerebral circulation 2013;44(5):1329-36.
2013: Jelena Kornej; Gregory Y H Lip; Andreas Bollmann
Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(5):620-2.
2013: Eva Jover; Francisco Marin; Silvia Montoro-García; Vanessa Roldán; Mariano Valdes; Gregory Y H Lip
Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.
Annals of medicine 2013;45(3):274-90.
2013: Vanessa Roldán; Mariano Valdés; Vicente Vicente; Hermógenes Fernández; Pilar Gallego; Sergio Manzano-Fernández; Francisco Marin; Gregory Y H Lip
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
The American journal of cardiology 2013;111(8):1159-64.
2013: Anna Gluba; Simon Hannam; Gregory Y H Lip; Dimitri P Mikhailidis; Jacek Rysz; Maciej Banach
Metabolic syndrome and renal disease.
International journal of cardiology 2013;164(2):141-50.
2013: Nikolaos Dagres; Thorsten Lewalter; Gregory Y H Lip; Laurent Pison; Alessandro Proclemer; Carina Blomstrom-Lundqvist
Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(4):478-81.
2013: Angelos A Kalitzeos; Rebekka Heitmar; Gregory Y H Lip
Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail?
American journal of hypertension 2013;26(4):454-5.
2013: Silvia Montoro-García; Esteban Orenes-Piñero; Ana Isabel Romero; Eduard Shantsila; Luke D Tapp; Mariano Valdés; Diana Hernández-Romero; Angel López-Cuenca; Sergio Manzano-Fernández; Francisco Marín; Gregory Y H Lip
Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
Atherosclerosis 2013;227(2):313-22.
2013: Eduard Shantsila; Alena Shantsila; Andrew D Blann; Gregory Y H Lip
Left ventricular fibrosis in atrial fibrillation.
The American journal of cardiology 2013;111(7):996-1001.
2013: Tatjana S Potpara; Marina M Licina; Jelena M Marinkovic; Marija M Polovina; Gregory Y H Lip
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
European journal of heart failure 2013;15(4):415-24.
2013: Gregory Y H Lip
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
European heart journal 2013;34(14):1041-9.
2013: George Ntaios; Vasileios Papavasileiou; Paraskevi Savvari; Eleni Koroboki; Gregory Y H Lip; Konstantinos Makaritsis; Efstathios Manios; Haralampos Milionis; Anastasia Vemmou; Konstantinos Vemmos
CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Neurology 2013;80(11):1009-17.
2013: Gregory Y H Lip
EUR Observational research programme: atrial fibrillation general registry pilot phase.
European heart journal 2013;34(11):794.
2013: A John Camm; R De Caterina; G Hindricks; S H Hohnloser; Gregory Y H Lip; I Savelieva; D Atar; Paulus Kirchhof
Questionable levels of evidence in new atrial fibrillation guidelines? Reply.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(3):461-2.
2013: A John Camm; R De Caterina; G Hindricks; Stefan H Hohnloser; Gregory Y H Lip; Irina Savelieva; D Atar; Paulus Kirchhof
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(3):460-1.
2013: Ron Pisters; Gregory Y H Lip
Safety and efficacy of new anticoagulants in patients with heart failure.
Current heart failure reports 2013;10(1):18-25.
2013: Andrew D Blann; Gregory Y H Lip
Atrial fibrillation and thrombosis: the missing molecular links.
Journal of the American College of Cardiology 2013;61(8):861-2.
2013: Gregory Y H Lip; Torben Bjerregaard Larsen; Flemming Skjøth; Lars Hvilsted Rasmussen
Reply.
Journal of the American College of Cardiology 2013;61(5):596.
2013: Gregory Y H Lip; Olga Shestakovska; Denis Xavier; Salim Yusuf; Stuart Connolly; John Eikelboom; Greg Flaker; Robert Hart; Fernando Lanas
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Circulation. Arrhythmia and electrophysiology 2013;6(1):31-8.
2013: Alessandro Proclemer; Carina Blomstrom-Lundqvist; Nikolaos Dagres; Gregory Y H Lip; Germanas Marinskis; Laurent Pison
Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(2):167-9.
2013: Ahmed M A Adlan; Gregory Y H Lip
Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
Drug safety : an international journal of medical toxicology and drug experience 2013;36(2):93-110.
2013: Diana Hernández-Romero; Eva Jover; Gregory Y H Lip; Sergio Manzano-Fernandez; Francisco Marin; Marta Romera; Mariano Valdes; Vicente Vicente; Juan A Vilchez; Vanessa Roldán
The prognostic role of the adiponectin levels in atrial fibrillation.
European journal of clinical investigation 2013;43(2):168-73.
2013: Benjamin J Wrigley; Eduard Shantsila; Luke D Tapp; Gregory Y H Lip
CD14++CD16+ monocytes in patients with acute ischaemic heart failure.
European journal of clinical investigation 2013;43(2):121-30.
2013: Pilar Gallego; Francisco Marin; Gregory Y H Lip
Prior aspirin therapy and cardiovascular implantable electronic device infections.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(2):163-4.
2013: Ron Pisters; Gregory Y H Lip
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?
The Canadian journal of cardiology 2013;29(2):139-41.
2013: Stavros Apostolakis; Harry Buller; Yutao Guo; Deirdre A Lane; Gregory Y H Lip
Reply.
Journal of the American College of Cardiology 2013;61(4):482-3.
2013: Stavros Apostolakis; Harry Buller; Yutao Guo; Deirdre A Lane; Gregory Y H Lip
Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients.
Journal of the American College of Cardiology 2013;61(3):386-7.
2013: Ajay K Kakkar; Gloria Kayani; Gregory Y H Lip; Lorenzo G Mantovani; Frank Misselwitz; Iris Mueller; Sophie Rushton-Smith; Alexander G G Turpie; Martin van Eickels; Freek W A Verheugt; Peter Wilkinson; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry.
PloS one 2013;8(5):e63479.
2013: Yousif Ahmad; Gregory Y H Lip
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Contributions to nephrology 2013;179():81-91.
2013: Rikke Sørensen; Christian Torp-Pedersen; Peter Weeke; Mette Charlot; Emil L Fosbøl; Gunnar Gislason; Morten W Hvidtfeldt; Deniz Karasoy; Lars Køber; Morten Lamberts; Gregory Y H Lip; Jonas Bjerring Olesen; Morten Lock Hansen
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.
BMJ open 2013;3(5):.
2013: Julia Chackathayil; Paramjit S Gill; Reinhard Heun; Elizabeth A Hughes; Deepthi Lavu; Ammar Natalwala; Jeetesh V Patel; Rahul Potluri; Hardeep Uppal; Gregory Y H Lip
Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia.
International journal of endocrinology 2013;2013():303859.
2013: Christian Weber; Gregory Y H Lip
A happy new year 2013 for Thrombosis and Haemostasis.
Thrombosis and haemostasis 2013;109(1):1-2.
2013: Eduard Shantsila; Gregory Y H Lip
Recent advances in management of atrial fibrillation in patients with heart failure.
Current opinion in cardiology 2013;28(2):197-208.
2013: Nicoletta Riva; Gregory Y H Lip
Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin- Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker?
Current pharmaceutical design 2013;19(21):3753-65.
2013: Gregory Y H Lip; Laurent Pison; Alessandro Proclemer; Jesper Hastrup Svendsen; Carina Blomstrom-Lundqvist; Nikolaos Dagres
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(1):141-3.
2013: Job Harenberg; Gregory Y H Lip
Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next?
QJM : monthly journal of the Association of Physicians 2013;106(1):95-6.
2013: Francisco Marin; Gregory Y H Lip
Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?
European journal of heart failure 2013;15(1):3-4.
2013: Andrew D Blann; Nadya Kuzniatsova; Gregory Y H Lip
Vascular and platelet responses to aspirin in patients with coronary artery disease.
European journal of clinical investigation 2013;43(1):91-9.
2013: Benjamin J Wrigley; Eduard Shantsila; Luke D Tapp; Gregory Y H Lip
Increased formation of monocyte-platelet aggregates in ischemic heart failure.
Circulation. Heart failure 2013;6(1):127-35.
2013: Angelos A Kalitzeos; Gregory Y H Lip; Rebekka Heitmar
Retinal vessel tortuosity measures and their applications.
Experimental eye research 2013;106():40-6.
2013: Jeetesh V Patel; Charlotte A Scarff; James H Scrivens; Inessa Tracey; Amitava Banerjee; Julia Chackathayil; Brian Gammon; Paramjit S Gill; Gregory Y H Lip; Adam Lovick; Elizabeth A Hughes
Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study.
Atherosclerosis 2013;226(1):198-200.
2013: Juan M Ruiz Nodar; Francisco Marín; Gregory Y H Lip
Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.
Revista española de cardiología (English ed.) 2013;66(1):12-6.
2013: Michiel Coppens; Paul Dorian; John W Eikelboom; Robert G Hart; Gregory Y H Lip; Olga Shestakovska; Salim Yusuf; Stuart J Connolly
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
European heart journal 2013;34(3):170-6.
2013: Luis Caballero; Jose A Hurtado; Sergio Manzano-Fernandez; Francisco Marín; Vanessa Roldán; Juan M Ruiz Nodar; Francisco Sogorb; Mariano Valdes; Jose Valencia; Gregory Y H Lip
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.
Age and ageing 2013;42(1):70-5.
2013: Vanessa Roldán; Mariano Valdés; Vicente Vicente; Hermógenes Fernández; Pilar Gallego; Sergio Manzano-Fernandez; Francisco Marin; Gregory Y H Lip
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
Chest 2013;143(1):179-84.
2012: Renee M Sullivan; Gideon Zamba; Jingyang Zhang; Gregory Y H Lip; Brian Olshansky
Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).
The American journal of cardiology 2012;110(12):1799-802.
2012: Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Inflammation in atrial fibrillation.
Journal of the American College of Cardiology 2012;60(22):2263-70.
2012: Yousif Ahmad; Gregory Y H Lip; Stavros Apostolakis
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation.
Expert review of cardiovascular therapy 2012;10(12):1471-80.
2012: Pilar Gallego; Eva Jover; Sergio Manzano-Fernández; Francisco Marin; Vanessa Roldán; Mariano Valdés; Vicente Vicente; Gregory Y H Lip
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation.
European journal of clinical investigation 2012;42(12):1302-8.
2012: Greg C Flaker; Andrzej Budaj; Stuart J Connolly; John W Eikelboom; Steen Husted; Scott Kaatz; Gregory Y H Lip; Olga Shestakovska; Salim Yusuf; Robert G Hart
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.
Stroke; a journal of cerebral circulation 2012;43(12):3291-7.
2012: Gregory Y H Lip; Carolyn M Brechin; Deirdre A Lane
The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe.
Chest 2012;142(6):1489-98.
2012: Nadzeya Kuzniatsova; Andrew Blann; Eduard Shantsila; Gregory Y H Lip
A contemporary viewpoint on 'aspirin resistance'.
Annals of medicine 2012;44(8):773-83.
2012: Francesco Dentali; Gregory Y H Lip; Nicoletta Riva; Alexander G G Turpie; Mark Crowther; Walter Ageno
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
Circulation 2012;126(20):2381-91.
2012: Maria Grazia Bongiorni; D Dobreanu; Gregory Y H Lip; Germanas Marinskis; Jesper Hastrup Svendsen; Carina Blomstrom-Lundqvist
How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(11):1666-9.
2012: Yousif Ahmad; Gregory Y H Lip
Stroke prevention in atrial fibrillation: concepts and controversies.
Current cardiology reviews 2012;8(4):290-301.
2012: Russell C Davis; F D Richard Hobbs; Rachel Iles; Joyce E Kenkre; Gregory Y H Lip; Andrea K Roalfe; Michael K Davies
Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(11):1553-9.
2012: Tatjana S Potpara; Petar M Seferovic; Goran R Stankovic; Jelena M Marinkovic; Miodrag C Ostojic; Marija M Polovina; Gregory Y H Lip
Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study.
International journal of cardiology 2012;161(1):39-44.
2012: Gregory Y H Lip; Sophie Taillandier; Amitava Banerjee; Isabelle Lagrenade; Deirdre A Lane; Laurent Fauchier
Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
Circulation. Arrhythmia and electrophysiology 2012;5(5):941-8.
2012: Iqbal S Toor; Rumi J Jaumdally; Gregory Y H Lip; TA Millane; Chetan Varma
Eosinophil count predicts mortality following percutaneous coronary intervention.
Thrombosis research 2012;130(4):607-11.
2012: Yousif Ahmad; Gregory Y H Lip
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.
Heart (British Cardiac Society) 2012;98(19):1404-6.
2012: Andrea K Roalfe; Samiramis Saba; Toni L Bryant; Matthew H Davies; Kate Fletcher; Thomas G Hackett; F D Richard Hobbs; Gregory Y H Lip; Jonathan Mant
A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(10):1420-7.
2012: Pilar Gallego; Stavros Apostolakis; Gregory Y H Lip
Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation.
Circulation 2012;126(13):1573-6.
2012: Ida Ehlers Albertsen; Torben Bjerregaard Larsen; Thure Filskov Overvad; Lars Hvilsted Rasmussen; Gregory Y H Lip
Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.
Drugs 2012;72(13):1755-64.
2012: A John Camm; Eduard Guasch; Jonathan L Halperin; Paulus Kirchhof; Gregory Y H Lip; Stanley Nattel; Matthew Needleman; Jeremy Ruskin; Irina Savelieva; Juan Viles-Gonzalez; Sana M Al-Khatib; Amitava Banerjee; Dan Blendea; Hugh Calkins; Eric S Williams
A proposal for new clinical concepts in the management of atrial fibrillation.
American heart journal 2012;164(3):292-302.e1.
2012: Tatjana S Potpara; Gregory Y H Lip; Stavros Apostolakis
New anticoagulant treatments to protect against stroke in atrial fibrillation.
Heart (British Cardiac Society) 2012;98(18):1341-7.
2012: Stavros Apostolakis; Harry Buller; Yutao Guo; Deirdre A Lane; Gregory Y H Lip
Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Journal of the American College of Cardiology 2012;60(9):861-7.
2012: Gregory Y H Lip; Torben Bjerregaard Larsen; Flemming Skjøth; Lars Hvilsted Rasmussen
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Journal of the American College of Cardiology 2012;60(8):738-46.
2012: Jonas Bjerring Olesen; Gunnar Hilmar Gislason; Kristine Hommel; Anne-Lise Kamper; Lars Køber; Deirdre A Lane; Jesper Lindhardsen; Gregory Y H Lip; Christian Torp-Pedersen
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
The New England journal of medicine 2012;367(7):625-35.
2012: Deirdre A Lane; Gregory Y H Lip
Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.
Circulation 2012;126(7):860-5.
2012: Alessandro Proclemer; Jesper Hastrup Svendsen; Dan Dobreanu; Gregory Y H Lip; Carina Blomström Lundqvist; Laurent Pison
Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(8):1195-8.
2012: Juan M Ruiz Nodar; Francisco Sogorb; Mariano Valdés; José Valencia; Luis Caballero; José A Hurtado; Sergio Manzano-Fernández; Francisco Marin; Vanessa Roldán; Gregory Y H Lip
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Circulation. Cardiovascular interventions 2012;5(4):459-66.
2012: Eduard Shantsila; Benjamin J Wrigley; Andrew D Blann; Paramjit S Gill; Gregory Y H Lip
A contemporary view on endothelial function in heart failure.
European journal of heart failure 2012;14(8):873-81.
2012: Jonas Bjerring Olesen; Gunnar Hilmar Gislason; Carolina Malta Hansen; Morten Lock Hansen; Deniz Karasoy; Lars Køber; Deirdre A Lane; Gregory Y H Lip; Christian Torp-Pedersen
Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
The American journal of medicine 2012;125(8):826.e13-23.
2012: Eduard Shantsila; Luke D Tapp; Benjamin J Wrigley; Angie Ghattas; Anthony Jaipersad; Silvia Montoro-Garcia; Gregory Y H Lip
The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates.
European journal of clinical investigation 2012;42(8):832-9.
2012: Gregory Y H Lip; Francisco Marin; Joao Morais; Piotr Ponikowski; Patrick Pullicino; Lars H Rasmussen; Felicita Andreotti; Stefan D Anker; Gerasimos Filippatos; Shunichi Homma; Deirdre A Lane
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
European journal of heart failure 2012;14(7):681-95.
2012: Eva Jover; Gregory Y H Lip; Pilar Gallego; Diana Hernández-Romero; Vanessa Roldán; Mariano Valdés; Vicente Vicente; Francisco Marin
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
Revista española de cardiología (English ed.) 2012;65(7):627-33.
2012: Rachael Boggon; Arlene M Gallagher; Gregory Y H Lip; Tjeerd P van Staa
Resource utilization and outcomes in patients with atrial fibrillation: a case control study.
Applied health economics and health policy 2012;10(4):249-59.
2012: Laurent Fauchier; Gregory Y H Lip; Céline Pellegrin; Denis Angoulvant; Anne Bernard; Nicolas Clementy; Dominique Babuty
Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries.
The American journal of cardiology 2012;110(1):7-12.
2012: Alena Shantsila; Eduard Shantsila; Richard P Steeds; Gareth Beevers; Girish Dwivedi; Gregory Y H Lip
Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project.
Hypertension research : official journal of the Japanese Society of Hypertension 2012;35(7):725-8.
2012: Sophie Taillandier; Dominique Babuty; Nicolas Clémenty; Isabelle Lagrenade; Gregory Y H Lip; Jonas B Olesen; Laurent Fauchier
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Journal of cardiovascular electrophysiology 2012;23(7):708-13.
2012: Chee W Khoo; Suresh Krishnamoorthy; Hoong Sern Lim; Gregory Y H Lip
Atrial fibrillation, arrhythmia burden and thrombogenesis.
International journal of cardiology 2012;157(3):318-23.
2012: Ingo Ahrens; Gregory Y H Lip; Karlheinz Peter; Christoph Bode
Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.
Discovery medicine 2012;13(73):445-50.
2012: Ingo Ahrens; Gregory Y H Lip; Karlheinz Peter; Christoph Bode
Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.
Discovery medicine 2012;13(73):433-43.
2012: Tatjana S Potpara; Milica S Prostran; Radan M Stojanovic; Marina M Licina; Marija M Polovina; Gregory Y H Lip
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Advances in therapy 2012;29(6):491-507.
2012: Ahmed M A Adlan; Gregory Y H Lip
Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation.
Chest 2012;141(6):1375-6.
2012: Vadim Tchaikovski; Gregory Y H Lip
Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?
Current hypertension reports 2012;14(3):183-92.
2012: Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
European heart journal 2012;33(12):1500-10.
2012: Francesco Violi; Gregory Y H Lip; Stefania Basili
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.
Internal and emergency medicine 2012;7(3):213-8.
2012: Shunichi Homma; Arthur J Labovitz; Bruce Levin; Gregory Y H Lip; Dirk J Lok; Douglas L Mann; Barry M Massie; Vilma Mejia; Jay P Mohr; Piotr Ponikowski; Patrick M Pullicino; Ralph L Sacco; Alexandra R Sanford; John R Teerlink; John L P Thompson; Susan E Ammon; Stefan D Anker; Richard Buchsbaum; Mirna L del Valle; Marco R Di Tullio; Conrado J Estol; Ronald S Freudenberger; Andre P Gabriel; Susan Graham
Warfarin and aspirin in patients with heart failure and sinus rhythm.
The New England journal of medicine 2012;366(20):1859-69.
2012: Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
Circulation 2012;125(19):2298-307.
2012: Torben Bjerregaard Larsen; Gregory Y H Lip; Kim Overvad; Flemming Skjøth; Karen Margrete Due; Lars Hvilsted Rasmussen
Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.
Circulation. Cardiovascular quality and outcomes 2012;5(3):335-42.
2012: Gregory Y H Lip; Alessandro Proclemer; Carina Blomstrom-Lundqvist; Maria Grazia Bongiorni; Nikolaus Dagres; Thorsten Lewalter
Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(5):741-4.
2012: Alena Shantsila; D Gareth Beevers; Deirdre A Lane; Gregory Y H Lip
Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study.
Journal of hypertension 2012;30(5):974-9.
2012: Will Foster; Gregory Y H Lip; Karim Raza; David Carruthers; Andrew D Blann
An observational study of endothelial function in early arthritis.
European journal of clinical investigation 2012;42(5):510-6.
2012: Raffaele De Caterina; Kurt Huber; Steen Husted; Jørgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; João Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Lars Wallentin; Jeffrey I Weitz; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
Journal of the American College of Cardiology 2012;59(16):1413-25.
2012: Gregory Y H Lip; A John Camm
Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation.
Revista española de cardiología (English ed.) 2012;65(4):390-1; author reply 391-2.
2012: Pilar Gallego; Josefa Gálvez; Francisco Marín; Vanessa Roldán; José Miguel Torregrosa; Mariano Valdés; Vicente Vicente; Gregory Y H Lip
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Circulation. Arrhythmia and electrophysiology 2012;5(2):312-8.
2012: Tatjana S Potpara; Milica S Prostran; Marina M Licina; Jelena M Marinkovic; Marija M Polovina; Gregory Y H Lip
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Circulation. Arrhythmia and electrophysiology 2012;5(2):319-26.
2012: Andrea Rubboli; Josè Valencia; Stephan Windecker; K E Juhani Airaksinen; Willem Dewilde; Eric Eeckhout; Istvàn Herzfeld; Kurt Huber; Gregory Y H Lip
The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.
Journal of interventional cardiology 2012;25(2):163-9.
2012: Vellore J Karthikeyan; Deirdre A Lane; Gregory Y H Lip; Sabah Baghdadi; D Gareth Beevers; Andrew D Blann
Angiogenin and hemoxygenase in pregnancy: influence of hypertension.
Angiology 2012;63(3):194-8.
2012: Eduard Shantsila; Viktor Snezhitskiy; Natallia Bialiuk; Paramjit S Gill; Dzmitry Navitski; Alexander Pyrochkin; Vladimir Pyrochkin; Gregory Y H Lip
Blood leukocytes in heart failure with preserved ejection fraction: impact on prognosis.
International journal of cardiology 2012;155(2):337-8.
2012: Mehmood Butt; Girish Dwivedi; Omer A Khair; Alena Shantsila; Gregory Y H Lip
Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy.
Circulation. Heart failure 2012;5(2):226-33.
2012: Giuseppe Boriani; Gianluca Botto; Alessandro Capucci; Maurizio Gasparini; Andrea Grammatico; Maurizio Landolina; Gregory Y H Lip; Maurizio Lunati; Luigi Padeletti; Alessandro Proclemer; Renato Pietro Ricci; Massimo Santini; Marco Vimercati; Stefano Bianchi; mauro biffi
Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
Circulation. Cardiovascular quality and outcomes 2012;5(2):182-8.
2012: Germanas Marinskis; Laurent Pison; Lieselot van Erven; Carina Blomström-Lundqvist; Maria Grazia Bongiorni; Gregory Y H Lip
Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(3):423-5.
2012: Hans-Christoph Diener; John Eikelboom; Graeme J Hankey; Robert G Hart; Stefan H Hohnloser; Campbell D Joyner; Gregory Y H Lip; Martin O'Donnell; Olga Shestakovska; Salim Yusuf; Stuart J Connolly
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.
Lancet neurology 2012;11(3):225-31.
2012: Amitava Banerjee; Benedicte Lallemand; Deirdre A Lane; Gregory Y H Lip; Jonas Bjerring Olesen; Sophie Taillandier; Laurent Fauchier
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.
European journal of heart failure 2012;14(3):295-301.
2012: Fausto Biancari; K E Juhani Airaksinen; Gregory Y H Lip
Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.
The Journal of thoracic and cardiovascular surgery 2012;143(3):665-675.e4.
2012: Gregory Y H Lip; Hung-Fat Tse; Deirdre A Lane
Atrial fibrillation.
Lancet 2012;379(9816):648-61.
2012: John J You; Mark H Eckman; Margaret C Fang; Alan S Go; Jonathan L Halperin; Patricia A Howard; Michael Hughes; Elaine M Hylek; Deirdre A Lane; Gregory Y H Lip; Warren J Manning; Sam Schulman; Daniel E Singer; Frederick A Spencer
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):e531S-75S.
2012: Konstantinos N Vemmos; Anastasia M Vemmou; Eleni Koroboki; Anna Kounali; Efstathios Manios; George Ntaios; Paraskevi Savvari; Gregory Y H Lip
Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study.
European journal of heart failure 2012;14(2):211-8.
2012: Athanasios J Manolis; Krzysztof Narkiewicz; Gianfranco Parati; Josep Redon; Enrico Agabiti Rosei; Roland Schmieder; Costas Tsioufis; Renata Cifkova; Antonio Coca; Serap E Erdine; Sverre Kjeldsen; Gregory Y H Lip; Giuseppe Mancia
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.
Journal of hypertension 2012;30(2):239-52.
2012: Gregory Y H Lip
Atrial fibrillation in 2011: Stroke prevention in AF.
Nature reviews. Cardiology 2012;9(2):71-3.
2012: Bob Weijs; Günter Breithardt; Jean-Yves Le Heuzey; Ione Limantoro; Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Ulrich Schotten; Panos E Vardas; Harry J G M Crijns
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(2):184-90.
2012: Dariusz Kozlowski; Gregory Y H Lip; Dimitri P Mikhailidis; Grzegorz Raczak; Jacek Rysz; Szymon Budrejko; Maciej Banach
Dronedarone: an overview.
Annals of medicine 2012;44(1):60-72.
2012: Tatjana S Potpara; Goran R Stankovic; Branko D Beleslin; Jelena M Marinkovic; Miodrag Ostojic; Marija M Polovina; Gregory Y H Lip
A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
Chest 2012;141(2):339-47.
2012: Sally Lee; Martina Brueckmann; Andreas Clemens; Brigitta U Monz; Gregory Y H Lip
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database.
BMJ open 2012;2(6):.
2012: Lars Hvilsted Rasmussen; Flemming Skjøth; Tina Graungaard; Torben Bjerregaard Larsen; Gregory Y H Lip
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.
BMJ (Clinical research ed.) 2012;345():e7097.
2012: Ron Pisters; Francisco Marin; A John Camm; Deirdre A Lane; Gregory Y H Lip
Stroke and thromboembolism in atrial fibrillation.
Circulation journal : official journal of the Japanese Circulation Society 2012;76(10):2289-304.
2012: Anette Luther Christensen; Claus Dethlefsen; Gregory Y H Lip; Lars Hvilsted Rasmussen; Michael G Baker; Torben Bjerregaard Larsen
Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand.
BMJ open 2012;2(4):.
2012: Stavros Apostolakis; Francisco Marín; Gregory Y H Lip
Antiplatelet therapy in stroke prevention.
Advances in cardiology 2012;47():141-54.
2012: Vanessa Roldán; Francisco Marin; Gregory Y H Lip
Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody.
Circulation journal : official journal of the Japanese Circulation Society 2012;76(8):1826-7.
2012: Gregory Y H Lip; Kim Overvad; Lars Hvilsted Rasmussen; Flemming Skjøth; Torben Bjerregaard Larsen
Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.
BMJ open 2012;2(4):.
2012: Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement.
Polskie Archiwum Medycyny Wewnętrznej 2012;122(5):235-42.
2012: Leif Friberg; Lina Benson; Mårten Rosenqvist; Gregory Y H Lip
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study.
BMJ (Clinical research ed.) 2012;344():e3522.
2012: Heli Lahtela; Gregory Y H Lip; Matti Niemelä; Marja Puurunen; Andrea Rubboli; Axel Schlitt; Josè Valencia; Saila Vikman; Michael Weber; K E Juhani Airaksinen; Fausto Biancari; Pasi Karjalainen
Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.
Circulation journal : official journal of the Japanese Circulation Society 2012;76(6):1363-8.
2012: Yousif Ahmad; Gregory Y H Lip
Stroke Prevention in Atrial Fibrillation: Where are We Now?
Clinical Medicine Insights. Cardiology 2012;6():65-78.
2012: Nicoletta Riva; Gregory Y H Lip
A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?
Polskie Archiwum Medycyny Wewnętrznej 2012;122(1-2):45-53.
2012: Burak Pamukcu; Kurt Huber; Gregory Y H Lip
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.
Current pharmaceutical design 2012;18(6):850-60.
2012: Gregory Y H Lip
Can we predict stroke in atrial fibrillation?
Clinical cardiology 2012;35 Suppl 1():21-7.
2012: Jonas Bjerring Olesen; Christian Torp-Pedersen; Gunnar Hilmar Gislason; Gregory Y H Lip
Atrial fibrillation and vascular disease--a bad combination.
Clinical cardiology 2012;35 Suppl 1():15-20.
2012: Vellore J Karthikeyan; Deirdre A Lane; Gregory Y H Lip; Sabah Baghdadi; D Gareth Beevers; Andrew D Blann
Soluble Fas and Fas ligand in pregnancy: influence of hypertension.
Angiology 2012;63(1):35-8.
2011: Silvia Montoro-García; Vanessa Roldán; Francisco Marin; Gregory Y H Lip
Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?
Thrombosis research 2011;128(6):601-2.
2011: Amitava Banerjee; Francisco Marín; Gregory Y H Lip
A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.
Stroke; a journal of cerebral circulation 2011;42(11):3316-22.
2011: Benjamin J Wrigley; Gregory Y H Lip; Eduard Shantsila
The role of monocytes and inflammation in the pathophysiology of heart failure.
European journal of heart failure 2011;13(11):1161-71.
2011: Nicoletta Riva; Danielle E Smith; Gregory Y H Lip; Deirdre A Lane
Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation.
Age and ageing 2011;40(6):653-5.
2011: Eduard Shantsila; Luke D Tapp; Benjamin Wrigley; Andrew D Blann; Paramjit S Gill; Alena Shantsila; Gregory Y H Lip
Ethnic differences in macrovascular and microvascular function in systolic heart failure.
Circulation. Heart failure 2011;4(6):754-62.
2011: Silvia Montoro-García; Eduard Shantsila; Andrew Blann; Francisco Marin; Gregory Y H Lip
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity.
Basic research in cardiology 2011;106(6):911-23.
2011: K E Juhani Airaksinen; Fausto Biancari; Pasi Karjalainen; Kari Kuttila; Timo Laitio; Reija Mikkola; Pekka Porela; Gregory Y H Lip
Safety of coronary artery bypass surgery during therapeutic oral anticoagulation.
Thrombosis research 2011;128(5):435-9.
2011: Ph Gabriel Steg; Alberto Garcia-Hernandez; C Michael Gibson; Christopher B Granger; J Wouter Jukema; Petr Kala; Frantisek Kovar; Gregory Y H Lip; Shamir R Mehta; Ronny W Renfurm
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
European heart journal 2011;32(20):2541-54.
2011: Gregory Y H Lip
The role of aspirin for stroke prevention in atrial fibrillation.
Nature reviews. Cardiology 2011;8(10):602-6.
2011: Francisco Marin; Irene Marín-Marín; Juan Gabriel Martínez; Antonio Hernández Madrid; Diana Hernández-Romero; Alicia Ibáñez; Gregory Y H Lip; Xavier Navarro; Mónica Ortego; Vanessa Roldán; Concepción Moro
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study.
Thrombosis research 2011;128(4):391-4.
2011: Daniela Poli; Sophie Testa; Emilia Antonucci; Elisa Grifoni; Oriana Paoletti; Gregory Y H Lip
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.
Chest 2011;140(4):918-24.
2011: Rumi J Jaumdally; Gregory Y H Lip; Chetan Varma; Andrew D Blann
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes.
Angiology 2011;62(7):571-8.
2011: Tatjana S Potpara; Goran Stankovic; Jelena M Stepanovic; Zorana M Vasiljevic; Bosiljka D Vujisic-Tesic; Jelena M Marinkovic; Miodrag C Ostojic; Marija M Polovina; Gregory Y H Lip
Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Chest 2011;140(4):902-10.
2011: Laurent Gorin; Dominique Babuty; Bernard Charbonnier; Laurent Fauchier; Emilie Nonin; Gregory Y H Lip
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.
Chest 2011;140(4):911-7.
2011: Amitava Banerjee; Gregory Y H Lip
Intracerebral hemorrhage and warfarin: perceived versus actual risk.
Stroke; a journal of cerebral circulation 2011;42(9):2383-4.
2011: Mehmood Butt; Girish Dwivedi; Omer A Khair; Alena Shantsila; Eduard Shantsila; Gregory Y H Lip
Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea.
Hypertension 2011;58(3):417-24.
2011: Danielle E Smith; Gregory Y H Lip; Deirdre A Lane
Strategies to improve oral anticoagulation management.
Chest 2011;140(2):281-2.
2011: Amitava Banerjee; Francisco Marín; Gregory Y H Lip
The improved but unfinished business of stroke risk stratification in atrial fibrillation.
Revista española de cardiología 2011;64(8):639-41.
2011: Burak Pamukcu; Gregory Y H Lip; Eduard Shantsila
The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease.
Thrombosis research 2011;128(2):117-23.
2011: Jonas Bjerring Olesen; Gregory Y H Lip; Deirdre A Lane
An epidemic of atrial fibrillation?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(8):1059-60.
2011: Rebekka Heitmar; Gregory Y H Lip; Robert P Cubbidge; Doina Gherghel; Andrew D Blann
Altered blood vessel responses in the eye and finger in coronary artery disease.
Investigative ophthalmology & visual science 2011;52(9):6199-205.
2011: Burak Pamukcu; Gregory Y H Lip; Viktor Snezhitskiy; Eduard Shantsila
The CD40-CD40L system in cardiovascular disease.
Annals of medicine 2011;43(5):331-40.
2011: Andrew D Blann; Balu Balakrishnan; Eduard Shantsila; Peter Ryan; Gregory Y H Lip
Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers.
The Prostate 2011;71(10):1047-53.
2011: Isla M Ogilvie; Sharon A Welner; Warren Cowell; Gregory Y H Lip
Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation.
The American journal of cardiology 2011;108(1):151-61.
2011: Deirdre A Lane; Harry R Büller; Pieter W Kamphuisen; Pascal Minini; Gregory Y H Lip
Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
Chest 2011;140(1):146-55.
2011: Khedar S Ramcharan; Gregory Y H Lip; Paul S Stonelake; Andrew D Blann
The endotheliome: a new concept in vascular biology.
Thrombosis research 2011;128(1):1-7.
2011: Vanessa Roldán; Jose Miguel Torregrosa; Mariano Valdés; Vicente Vicente; Diana Hernández-Romero; Francisco Marin; Begoña Muiña; Gregory Y H Lip
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Journal of the American College of Cardiology 2011;57(25):2496-504.
2011: Sue Jowett; Stirling Bryan; Jonathan Mant; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; F D Richard Hobbs
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
Stroke; a journal of cerebral circulation 2011;42(6):1717-21.
2011: Giuseppe Boriani; Gianluca Botto; Alessandro Capucci; Giorgio Corbucci; Tiziana De Santo; Michele Gulizia; Gregory Y H Lip; Luigi Padeletti; Renato Ricci; Massimo Santini; mauro biffi
Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring.
Stroke; a journal of cerebral circulation 2011;42(6):1768-70.
2011: Silvia Montoro-García; Peck Lin Lip; Chi-Chao Chan; Gregory Y H Lip
Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?
The British journal of ophthalmology 2011;95(6):757-8.
2011: V J Karthikeyan; Andrew D Blann; Sabah Baghdadi; Deirdre A Lane; D Gareth Beevers; Gregory Y H Lip
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(6):531-7.
2011: Juan M Ruiz Nodar; Francisco Sogorb; Mariano Valdés; José Valencia-Martín; Sergio Manzano-Fernández; Francisco Marín; Eduardo Pinar; Javier Pineda; Vanessa Roldán; José A Hurtado; Gregory Y H Lip
An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.
Chest 2011;139(6):1402-9.
2011: Kevin Damman; Marie J Ng Kam Chuen; Robert J MacFadyen; Gregory Y H Lip; David Gaze; Paul O Collinson; Hans L Hillege; Wim van Oeveren; Adriaan Voors; Dirk J van Veldhuisen
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Journal of the American College of Cardiology 2011;57(22):2233-41.
2011: Andrea Rubboli; Jason C Kovacic; Roxana Mehran; Gregory Y H Lip
Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options.
Chest 2011;139(5):981-7.
2011: Carina Blomstrom-Lundqvist; Gregory Y H Lip; Paulus Kirchhof
What are the costs of atrial fibrillation?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13 Suppl 2():ii9-12.
2011: Gregory Y H Lip; Felicita Andreotti; Laurent Fauchier; Kurt Huber; Elaine Hylek; Eve Knight; Deirdre A Lane; Marcel Levi; Francisco Marin; Gualtiero Palareti; Paulus Kirchhof; Jean-Philippe Collet; Andrea Rubboli; Daniela Poli; John Camm
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(5):723-46.
2011: Olav R de Peuter; Gregory Y H Lip; Patrick C Souverein; Olaf Klungel; Anthonius de Boer; Harry R Büller; Pieter W Kamphuisen
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
European journal of heart failure 2011;13(5):489-95.
2011: Junette S Mohan; Gregory Y H Lip; Andrew D Blann; David Bareford; Janice M Marshall
Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.
European journal of clinical investigation 2011;41(5):546-51.
2011: L Y Ho; Chung Wah SIU; W S Yue; Chu-Pak Lau; Gregory Y H Lip; Hung-Fat Tse
Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension.
Journal of human hypertension 2011;25(5):304-10.
2011: Gregory Y H Lip; Jonathan L Halperin; Hung-Fat Tse
The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?
Chest 2011;139(4):738-41.
2011: Nadzeya Kuzniatsova; Gregory Y H Lip
Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?
International journal of cardiology 2011;148(1):1-3.
2011: Ricarda Marinigh; Deirdre A Lane; Gregory Y H Lip
Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk.
Journal of the American College of Cardiology 2011;57(12):1339-48.
2011: Alena Shantsila; Girish Dwivedi; Eduard Shantsila; Mehmood Butt; D Gareth Beevers; Gregory Y H Lip
Persistent macrovascular and microvascular dysfunction in patients with malignant hypertension.
Hypertension 2011;57(3):490-6.
2011: Eduard Shantsila; Gregory Y H Lip
The risk of thromboembolism in heart failure: does it merit anticoagulation therapy?
The American journal of cardiology 2011;107(4):558-60.
2011: Luke D Tapp; Gregory Y H Lip; Deirdre A Lane
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".
Chest 2011;139(2):240-2.
2011: Angie Ghattas; Eduard Shantsila; Gregory Y H Lip
Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.
Therapeutic advances in cardiovascular disease 2011;5(1):5-9.
2011: Gregory Y H Lip; Lars H Rasmussen; S Bertil Olsson; Sofia Zetterstrand; Christina Stahre; Anders Bylock; Maria Aunes-Jansson; Ulf Eriksson; Karin Wåhlander
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Thrombosis research 2011;127(2):91-9.
2011: Gregory Y H Lip
Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(2):145-8.
2011: Vellore J Karthikeyan; Robin E Ferner; Sabah Baghdadi; Deirdre A Lane; Gregory Y H Lip; D Gareth Beevers
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies.
Journal of hypertension 2011;29(2):396-9.
2011: Gregory Y H Lip
Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.
The American journal of medicine 2011;124(2):111-4.
2011: Silvia Montoro-García; Eduard Shantsila; Gregory Y H Lip
Platelet reactivity in prolonged stress disorders--a link with cardiovascular disease?
Psychoneuroendocrinology 2011;36(2):159-60.
2011: Chee W Khoo; Suresh Krishnamoorthy; Hoong Sern Lim; Gregory Y H Lip
Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(2):97-105.
2011: Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
Journal of the American College of Cardiology 2011;57(2):173-80.
2011: Paramjit S Gill; Melanie Calvert; Michael K Davies; Russell Davis; Nick Freemantle; Gregory Y H Lip
Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).
PloS one 2011;6(11):e26710.
2011: Amitava Banerjee; Gregory Y H Lip
Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.
Cerebrovascular diseases (Basel, Switzerland) 2011;32(4):383-4.
2011: Gregory Y H Lip; Stavros Apostolakis
Atrial fibrillation (acute onset).
Clinical evidence 2011;2011():.
2011: Vellore J Karthikeyan; Gregory Y H Lip
Endothelial damage/dysfunction and hypertension in pregnancy.
Frontiers in bioscience (Elite edition) 2011;3():1100-8.
2011: Jonas Bjerring Olesen; Gregory Y H Lip; Morten Lock Hansen; Peter Riis Hansen; Janne Schurmann Tolstrup; Jesper Lindhardsen; Christian Selmer; Ole Ahlehoff; Anne-Marie Schjerning Olsen; Gunnar H Gislason; Christian Torp-Pedersen
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
BMJ (Clinical research ed.) 2011;342():d124.
2011: Gregory Y H Lip; Christian Weber
Clinical and basic science articles from Thrombosis and Haemostasis.
Thrombosis and haemostasis 2011;105(1):202-5.
2011: Kok Hoon Tay; Gregory Y H Lip; Deirdre A Lane
Can we IMPROVE bleeding risk assessment for acutely ill, hospitalized medical patients?
Chest 2011;139(1):10-3.
2011: Selvakumar Velu; Gregory Y H Lip
What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?
Advances in therapy 2011;28(1):1-12.
2011: Burak Pamukcu; Gregory Y H Lip
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
Expert opinion on pharmacotherapy 2011;12(1):131-40.
2011: Silvia Montoro-García; Francisco Marín; Gregory Y H Lip
Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(1):3-4.
2010: Stephan H Schirmer; Magnus Baumhäkel; Hans-Ruprecht Neuberger; Stefan H Hohnloser; Isabelle C Van Gelder; Gregory Y H Lip; Michael Böhm
Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
Journal of the American College of Cardiology 2010;56(25):2067-76.
2010: Gurbir S Bhatia; Michael D Sosin; Jeetesh Patel; Karl A Grindulis; Fazal H Khattak; Russell C Davis; Gregory Y H Lip
Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function.
International journal of cardiology 2010;145(3):e105-8.
2010: Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.
Stroke; a journal of cerebral circulation 2010;41(12):2731-8.
2010: Angel López-Cuenca; Francisco Marin; Vanessa Roldán; Rocío González-Conejero; Diana Hernández-Romero; Mariano Valdés; Gregory Y H Lip
Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.
Annals of medicine 2010;42(8):562-75.
2010: Michael D Ezekowitz; Lars Wallentin; Stuart J Connolly; Amit Parekh; Michael R Chernick; Janice Pogue; Timothy H Aikens; Sean Yang; Paul A Reilly; Gregory Y H Lip; Salim Yusuf
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Circulation 2010;122(22):2246-53.
2010: Nadzeya Kuzniatsova; Gregory Y H Lip
How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke?
Journal of the neurological sciences 2010;298(1-2):21-2.
2010: Alena Shantsila; Eduard Shantsila; Gregory Y H Lip
Malignant hypertension: a rare problem or is it underdiagnosed?
Current vascular pharmacology 2010;8(6):775-9.
2010: Rebekka Heitmar; Andrew D Blann; Robert P Cubbidge; Gregory Y H Lip; Doina Gherghel
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?
Investigative ophthalmology & visual science 2010;51(11):5833-9.
2010: Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Chest 2010;138(5):1093-100.
2010: Trini Closa León; Arie Nouwen; David Sheffield; Rumi Jaumdally; Gregory Y H Lip
Anger rumination, social support, and cardiac symptoms in patients undergoing angiography.
British journal of health psychology 2010;15(Pt 4):841-57.
2010: Benjamin J Wrigley; Eduard Shantsila; Gregory Y H Lip
Percutaneous coronary intervention in anticoagulated patients and balancing the risk of stroke and bleeding: to interrupt or not to interrupt?
Chest 2010;138(4):771-4.
2010: Burak Pamukcu; Eduard Shantsila; Gregory Y H Lip
Soluble fms-like tyrosine kinase-1 – a novel marker for atherosclerotic progression? –.
Circulation journal : official journal of the Japanese Circulation Society 2010;74(10):2064-5.
2010: Jeetesh Patel; I Tracey; E A Hughes; Gregory Y H Lip
Omega-3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?
Journal of thrombosis and haemostasis : JTH 2010;8(10):2095-104.
2010: Mette Bjerre; Caroline Kistorp; Troels Krarup Hansen; Jens Faber; Gregory Y H Lip; Per Hildebrandt; Allan Flyvbjerg
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure.
Scandinavian cardiovascular journal : SCJ 2010;44(5):260-6.
2010: Deirdre A Lane; Gregory Y H Lip
Quality of anticoagulation control in atrial fibrillation.
Lancet 2010;376(9745):935-7.
2010: Ricarda Marinigh; Gregory Y H Lip; Nicola Fiotti; Carlo Giansante; Deirdre A Lane
Age as a risk factor for stroke in atrial fibrillation patients implications for thromboprophylaxis: Implications for thromboprophylaxis.
Journal of the American College of Cardiology 2010;56(11):827-37.
2010: Javier Pineda; Francisco Marin; Pascual Marco; Vanessa Roldán; José Valencia; Juan M Ruiz Nodar; Diana Hernández Romero; Francisco Sogorb; Gregory Y H Lip
The prognostic value of biomarkers after a premature myocardial infarction.
International journal of cardiology 2010;143(3):249-54.
2010: K E Juhani Airaksinen; Axel Schlitt; Andrea Rubboli; Pasi Karjalainen; Gregory Y H Lip
How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;6(4):520-6.
2010: Deirdre A Lane; Gregory Y H Lip
Atrial fibrillation and mortality: the impact of antithrombotic therapy.
European heart journal 2010;31(17):2075-6.
2010: Gregory Y H Lip; Deirdre A Lane
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
The American journal of medicine 2010;123(9):785-9.
2010: Burak Pamukcu; Gregory Y H Lip; Andrew Devitt; Helen Griffiths; Eduard Shantsila
The role of monocytes in atherosclerotic coronary artery disease.
Annals of medicine 2010;42(6):394-403.
2010: Burak Pamukcu; Gregory Y H Lip; Deirdre A Lane
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores.
Age and ageing 2010;39(5):533-5.
2010: Suresh Krishnamoorthy; Mehmood Butt; Gregory Y H Lip
Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.
International journal of cardiology 2010;143(2):e34-6.
2010: Nadzeya Kuzniatsova; Eduard Shantsila; Gregory Y H Lip
Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
Nature reviews. Cardiology 2010;7(8):428-30.
2010: Eric N Prystowsky; John Camm; Gregory Y H Lip; Maurits Allessie; Jean-François Bergmann; Günter Breithardt; Josep Brugada; Harry Crijns; Patrick T Ellinor; Daniel Mark; Gerald Naccarelli; Douglas Packer; Juan Tamargo
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
Journal of cardiovascular electrophysiology 2010;21(8):946-58.
2010: Isla M Ogilvie; Nick Newton; Sharon A Welner; Warren Cowell; Gregory Y H Lip
Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
The American journal of medicine 2010;123(7):638-645.e4.
2010: Benjamin J Wrigley; Gregory Y H Lip; Eduard Shantsila
Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice.
International journal of clinical practice 2010;64(7):835-8.
2010: Gregory Y H Lip; Jonathan L Halperin
Improving stroke risk stratification in atrial fibrillation.
The American journal of medicine 2010;123(6):484-8.
2010: Gregory Y H Lip; Kurt Huber; Felicita Andreotti; Harald Arnesen; Juhani K Airaksinen; Thomas Cuisset; Paulus Kirchhof; Francisco Marín
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
European heart journal 2010;31(11):1311-8.
2010: Laurent Fauchier; Gregory Y H Lip
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(6):761-3.
2010: E Aliot; Günter Breithardt; Josep Brugada; John Camm; Gregory Y H Lip; Panos E Vardas; Markus Wagner
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(5):626-33.
2010: Karlheinz Peter; Gregory Y H Lip
Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy.
Thrombosis and haemostasis 2010;103(5):875-6.
2010: Danielle Smith; Gregory Y H Lip; Deirdre A Lane
Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(5):608-10.
2010: Deirdre A Lane; Gregory Y H Lip
Anticoagulation for atrial fibrillation patients with CHADS score of 1.
Journal of cardiovascular electrophysiology 2010;21(5):508-10.
2010: Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.
Journal of thrombosis and thrombolysis 2010;29(4):437-42.
2010: Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
The Journal of rheumatology 2010;37(4):711-6.
2010: Camilla Noelle Rathcke; Caroline Kistorp; Ilan Raymond; Per Hildebrandt; Finn Gustafsson; Gregory Y H Lip; Jens Faber; Henrik Vestergaard
Plasma YKL-40 levels are elevated in patients with chronic heart failure.
Scandinavian cardiovascular journal : SCJ 2010;44(2):92-9.
2010: Chung Wah SIU; Timothy Watson; Wing-Hon Lai; Yee-Ki Lee; Yap-Hang Chan; Kwong-Man Ng; Chu-Pak Lau; Gregory Y H Lip; Hung-Fat Tse
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(4):517-21.
2010: Timothy Watson; Anita Arya; Neil Sulke; Gregory Y H Lip
Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.
Chest 2010;137(4):869-76.
2010: Dariusz Kozlowski; Szymon Budrejko; Gregory Y H Lip; Jacek Rysz; Dimitri P Mikhailidis; Grzegorz Raczak; Maciej Banach
Lone atrial fibrillation: what do we know?
Heart (British Cardiac Society) 2010;96(7):498-503.
2010: Benjamin J Wrigley; Gregory Y H Lip; Eduard Shantsila
Coronary atherosclerosis in rheumatoid arthritis: could endothelial progenitor cells be the missing link?
The Journal of rheumatology 2010;37(3):479-81.
2010: Chee W Khoo; Gregory Y H Lip
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
Expert opinion on pharmacotherapy 2010;11(4):685-7.
2010: Jeetesh Patel; Abraheem Abraheem; John Creamer; Mark Gunning; Elizabeth A Hughes; Gregory Y H Lip
Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.
European journal of heart failure 2010;12(3):254-9.
2010: Joe Gray; Steven J Edwards; Gregory Y H Lip
Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.
Current medical research and opinion 2010;26(3):537-47.
2010: Stavros Apostolakis; Gregory Y H Lip; Eduard Shantsila
Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?
Cardiovascular research 2010;85(4):649-60.
2010: Mehmood Butt; Girish Dwivedi; Omer Khair; Gregory Y H Lip
Obstructive sleep apnea and cardiovascular disease.
International journal of cardiology 2010;139(1):7-16.
2010: Angel López-Cuenca; Francisco Marín; Vanessa Roldán; Vicente E Climent; Mariano Valdés; Gregory Y H Lip
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease.
International journal of cardiology 2010;139(1):95-7.
2010: Luke Tapp; Eduard Shantsila; Gregory Y H Lip
Aspirin--a drug whose time has gone?
The American journal of cardiology 2010;105(4):577-8.
2010: Antonio Tello-Montoliu; Francisco Marin; Vanessa Roldán; Gregory Y H Lip
The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?
Heart (British Cardiac Society) 2010;96(3):227-8; author reply 228.
2010: Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
Chest 2010;137(2):263-72.
2010: Mehmood Butt; Girish Dwivedi; Andrew Blann; Omer Khair; Gregory Y H Lip
Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases.
Current pharmaceutical design 2010;16(31):3442-54.
2010: Tatjana Potpara; Gregory Y H Lip
Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation.
Current pharmaceutical design 2010;16(31):3455-71.
2010: Andrea Rubboli; Axel Schlitt; Juhani Airaksinen; Gregory Y H Lip
Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;5(6):649-50; author reply 651.
2010: Christian Weber; Gregory Y H Lip
Moving forward with a new editorial team for Thrombosis and Haemostasis.
Thrombosis and haemostasis 2010;103(1):1-2.
2010: Gregory Y H Lip; Kurt Huber; Felicita Andreotti; Harald Arnesen; K Juhani Airaksinen; Thomas Cuisset; Paulus Kirchhof; Francisco Marín
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
Thrombosis and haemostasis 2010;103(1):13-28.
2009: Kok-Hoon Tay; Deirdre Lane; Gregory Y H Lip
Balancing thromboembolism and bleeding risks: insights from anticoagulation for prosthetic heart valves.
Chest 2009;136(6):1451-2.
2009: Veeran Subramaniam; Russell C Davis; Eduard Shantsila; Gregory Y H Lip
Antithrombotic therapy for heart failure in sinus rhythm.
Fundamental & clinical pharmacology 2009;23(6):705-17.
2009: P K Kong; D Connolly; C Varma; Gregory Y H Lip; TA Millane; R Davis; R Ahmad
High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients.
International journal of clinical practice 2009;63(12):1693-701.
2009: Gregory Y H Lip; Lars H Rasmussen; S Bertil Olsson; Eva C Jensen; Anders L Persson; Ulf Eriksson; Karin F C Wåhlander
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.
European heart journal 2009;30(23):2897-907.
2009: Timothy Watson; Vellore J Karthikeyan; Gregory Y H Lip; D Gareth Beevers
Atrial fibrillation in primary aldosteronism.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2009;10(4):190-4.
2009: Paulus Kirchhof; Jeroen Bax; Carina Blomstrom-Lundquist; Hugh Calkins; A John Camm; Ricardo Cappato; Francisco Cosio; Harry Crijns; Hans-Christian Diener; Alessandra D'Alessandro; Carsten W Israel; Karl-Heinz Kuck; Gregory Y H Lip; Stanley Nattel; Richard L Page; Ursula Ravens; Ulrich Schotten; Gerhard Steinbeck; Panos Vardas; Albert Waldo; Karl Wegscheider; Stephan Willems; Günter Breithardt
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
European heart journal 2009;30(24):2969-77c.
2009: Stavros Apostolakis; Eduard Shantsila; Gregory Y H Lip
Evidence guided antiplatelet treatment: time to move from bench to bedside.
Thrombosis research 2009;124(6):649-50.
2009: Eduard Shantsila; Gregory Y H Lip
The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms.
Thrombosis and haemostasis 2009;102(5):916-24.
2009: Stavros Apostolakis; Eduard Shantsila; Gregory Y H Lip; Deirdre Lane
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Thrombosis and haemostasis 2009;102(5):914-5.
2009: Deirdre Lane; Gregory Y H Lip; D Gareth Beevers
Improving survival of malignant hypertension patients over 40 years.
American journal of hypertension 2009;22(11):1199-204.
2009: Stavros Apostolakis; Eduard Shantsila; Gregory Y H Lip
Vascular imaging as a cardiovascular risk stratification tool in systemic lupus erythematosus.
The Journal of rheumatology 2009;36(10):2141-3.
2009: Alena Shantsila; Gregory Y H Lip
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.
Evidence-based medicine 2009;14(5):142.
2009: Luke Tapp; Ben Wrigley; Gregory Y H Lip
Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes.
Nature reviews. Cardiology 2009;6(10):619-20.
2009: Eduard Shantsila; Gregory Y H Lip
Monocytes in acute coronary syndromes.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1433-8.
2009: Gregory Y H Lip; Deirdre Lane
Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients.
Revista española de cardiología 2009;62(9):972-5.
2009: John Ip; Albert L Waldo; Gregory Y H Lip; Peter M Rothwell; David T Martin; Malcolm M Bersohn; Wassim K Choucair; Joseph G Akar; Mark S Wathen; Pooyan Rohani; Jonathan L Halperin
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
American heart journal 2009;158(3):364-370.e1.
2009: Suresh Krishnamoorthy; Gregory Y H Lip; Deirdre Lane
Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review.
The American journal of medicine 2009;122(9):851-856.e3.
2009: Alena Shantsila; Gregory Y H Lip
ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.
Annals of internal medicine 2009;151(4):JC2-11.
2009: Javier Pineda; Francisco Marin; Pascual Marco; Vanessa Roldán; José Valencia; Juan M Ruiz Nodar; Francisco Sogorb; Gregory Y H Lip
Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
International journal of cardiology 2009;136(2):222-5.
2009: Eduard Shantsila; Gregory Y H Lip
The endothelium and thrombotic risk in heart failure.
Thrombosis and haemostasis 2009;102(2):185-7.
2009: Patrick K Y Goon; Gregory Y H Lip; Paul S Stonelake; Andrew D Blann
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Neoplasia (New York, N.Y.) 2009;11(8):771-9.
2009: Stavros Apostolakis; Eduard Shantsila; Gregory Y H Lip
Angiopoietins and preeclampsia: new perspectives in the quest for markers.
American journal of hypertension 2009;22(8):820.
2009: Eduard Shantsila; Gregory Y H Lip
Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?
Journal of hypertension 2009;27(8):1524-6.
2009: Suresh Krishnamoorthy; Gregory Y H Lip
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
Expert opinion on investigational drugs 2009;18(8):1191-6.
2009: Hoong Sern Lim; Gregory Y H Lip
Defibrillation testing in patients with atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(8):1108-9.
2009: Eduard Shantsila; Gregory Y H Lip
Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(4):401-3.
2009: Eduard Shantsila; Gregory Y H Lip
Monocyte diversity in myocardial infarction.
Journal of the American College of Cardiology 2009;54(2):139-42.
2009: Francisco Marín; Paulus Kirchhof; Gregory Y H Lip
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):842-3.
2009: Suresh Krishnamoorthy; Gregory Y H Lip
How safe is the antiarrhythmic drug therapy in atrial fibrillation?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):837-9.
2009: Paulus Kirchhof; Jeroen Bax; Carina Blomstrom-Lundquist; Hugh Calkins; A John Camm; Ricardo Cappato; Francisco Cosio; Harry Crijns; Hans-Christian Diener; Alessandra D'Alessandro; Carsten W Israel; Karl-Heinz Kuck; Gregory Y H Lip; Stanley Nattel; Richard L Page; Ursula Ravens; Ulrich Schotten; Gerhard Steinbeck; Panos Vardas; Albert Waldo; Karl Wegscheider; Stephan Willems; Günter Breithardt
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):860-85.
2009: Ashan Gunarathne; Jeetesh Patel; Shahid Kausar; Brian Gammon; Elizabeth A Hughes; Gregory Y H Lip
Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project.
Stroke; a journal of cerebral circulation 2009;40(7):2298-306.
2009: Chee W Khoo; Gregory Y H Lip
Can the NICE guidelines on the management of atrial fibrillation improve its management?
Clinical medicine (London, England) 2009;9(3):207-9.
2009: Eduard Shantsila; Gregory Y H Lip; Beng H Chong
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Chest 2009;135(6):1651-64.
2009: Philip C Bennett; Stanley H Silverman; Paramjit S Gill; Gregory Y H Lip
Peripheral arterial disease and Virchow's triad.
Thrombosis and haemostasis 2009;101(6):1032-40.
2009: Ashan Gunarathne; Jeetesh Patel; Brian Gammon; Paramjit S Gill; Elizabeth A Hughes; Gregory Y H Lip
Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features.
Stroke; a journal of cerebral circulation 2009;40(6):e415-23.
2009: Deirdre Lane; Gregory Y H Lip
Quality of life in older people with atrial fibrillation.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2009;25(1):37-42.
2009: Kok Hoon Tay; Chee Wah Khoo; Gregory Y H Lip
Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
The Journal of heart valve disease 2009;18(3):276-7.
2009: Suresh Krishnamoorthy; Gregory Y H Lip
Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
Expert review of cardiovascular therapy 2009;7(5):473-81.
2009: Deirdre Lane; Gregory Y H Lip
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
Thrombosis and haemostasis 2009;101(5):802-5.
2009: Michele Brignole; Panos Vardas; Ellen Hoffman; Heikki Huikuri; Angel Moya; Renato Ricci; Neil Sulke; Wouter Wieling; Angelo Auricchio; Gregory Y H Lip; Jesus Almendral; Paulus Kirchhof; Etienne Aliot; Maurizio Gasparini; Frieder Braunschweig; Gregory Y H Lip; Jesus Almendral; Paulus Kirchhof; Gian Luca Botto
Indications for the use of diagnostic implantable and external ECG loop recorders.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(5):671-87.
2009: Chee W Khoo; Gregory Y H Lip
Burden of atrial fibrillation.
Current medical research and opinion 2009;25(5):1261-3.
2009: Xin Du; Toshiharu Ninomiya; Bastiaan de Galan; Edward Abadir; John Chalmers; Avinesh Pillai; Mark Woodward; Mark Cooper; Stephen Harrap; Pavel Hamet; Neil Poulter; Gregory Y H Lip; Anushka Patel
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
European heart journal 2009;30(9):1128-35.
2009: Gurbir S Bhatia; Michael D Sosin; Jeetesh Patel; Karl A Grindulis; Fazal H Khattak; Russell C Davis; Gregory Y H Lip
Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
International journal of cardiology 2009;134(1):97-103.
2009: Chee W Khoo; Gregory Y H Lip
Clinical outcomes of acute stroke patients with atrial fibrillation.
Expert review of cardiovascular therapy 2009;7(4):371-4.
2009: Jeetesh Patel; Inessa Tracey; Elizabeth A Hughes; Gregory Y H Lip
Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines.
Expert review of cardiovascular therapy 2009;7(4):337-40.
2009: Ali Hamaad; Michael D Sosin; Andrew D Blann; Gregory Y H Lip; Robert J MacFadyen
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
Clinical cardiology 2009;32(4):204-9.
2009: Juan M Ruiz Nodar; Francisco Marin; José Sánchez Payá; José A Hurtado; José Valencia-Martín; Sergio Manzano-Fernández; Vanessa Roldán; Virginia Pérez-Andreu; Francisco Sogorb; Mariano Valdés; Gregory Y H Lip
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.
European heart journal 2009;30(8):932-9.
2009: Sergio Manzano-Fernández; Francisco Marin; Francisco J Pastor-Pérez; Cesar Caro; Francisco Cambronero; Javier Lacunza; Eduardo Pinar; Domingo A Pascual Figal; Mariano Valdés; Gregory Y H Lip
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting.
Chest 2009;135(4):983-90.
2009: Mehmood Butt; Derek Connolly; Gregory Y H Lip
Drug-eluting stents: a comprehensive appraisal.
Future cardiology 2009;5(2):141-57.
2009: Kok Hoon Tay; Gregory Y H Lip; Deirdre Lane
Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Thrombosis and haemostasis 2009;101(3):415-6.
2009: Chee W Khoo; Gregory Y H Lip
Acute management of atrial fibrillation.
Chest 2009;135(3):849-59.
2009: Deirdre Lane; Caroline M Langman; Gregory Y H Lip; Arie Nouwen
Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation.
Journal of psychosomatic research 2009;66(3):203-10.
2009: Kok Hoon Tay; Deirdre Lane; Gregory Y H Lip
Challenges facing anticoagulation among the elderly and frail.
Age and ageing 2009;38(2):140-2.
2009: Will Foster; Eduard Shantsila; David M Carruthers; Gregory Y H Lip; Andrew D Blann
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
Rheumatology (Oxford, England) 2009;48(3):285-8.
2009: Vicente Climent; Francisco Marín; Luis Mainar; Vanessa Roldán; Amaya García; Juan Gabriel Martínez; Gregory Y H Lip
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
International journal of cardiology 2009;132(2):227-32.
2009: Eduard Shantsila; Gregory Y H Lip
Variability of response to antiplatelet therapy: what should we do next?
Fundamental & clinical pharmacology 2009;23(1):19-22.
2009: Diana Kaireviciute; Audrius Aidietis; Gregory Y H Lip
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies.
European heart journal 2009;30(4):410-25.
2009: Kate Jolly; Rod S Taylor; Gregory Y H Lip; Mick Davies; Russell Davis; Jonathan Mant; Sally Singh; Sheila Greenfield; Jackie Ingram; Jane Stubley; Stirling Bryan; Andrew J Stevens
A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.
European journal of heart failure 2009;11(2):205-13.
2009: Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.
Thrombosis research 2009;123(4):659-64.
2009: Timothy Watson; Eduard Shantsila; Gregory Y H Lip
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
Lancet 2009;373(9658):155-66.
2009: Shahirose S Jessani; Deirdre A Lane; Eduard Shantsila; Timothy Watson; Teri A Millane; Gregory Y H Lip
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction.
Annals of medicine 2009;41(8):608-18.
2009: Shahirose Jessani; TA Millane; Gregory Y H Lip
Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?
Current pharmaceutical design 2009;15(29):3417-32.
2009: Jeetesh Patel; Inessa Tracey; Elizabeth A Hughes; Gregory Y H Lip
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.
Vascular health and risk management 2009;5():801-10.
2009: Stavros Apostolakis; Eduard Shantsila; Gregory Y H Lip
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
PharmacoEconomics 2009;27(10):793-5.
2009: Suresh Krishnamoorthy; Sern H Lim; Gregory Y H Lip
Assessment of endothelial (dys)function in atrial fibrillation.
Annals of medicine 2009;41(8):576-90.
2009: Marie J Ng Kam Chuen; Gregory Y H Lip; Robert J Macfadyen
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.
Cardiovascular therapeutics 2009;27(2):89-95.
2009: Deepak Goyal; Ing-Marie Logie; Sunil K Nadar; Gregory Y H Lip; Robert J MacFadyen
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.
Cardiovascular therapeutics 2009;27(1):10-6.
2009: Jeetesh Patel; Hoong S Lim; Kiran Dubb; Elizabeth A Hughes; Gregory Y H Lip
Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.
Annals of medicine 2009;41(4):291-300.
2009: Francisco Cambronero; Francisco Marín; Vanessa Roldán; Diana Hernández-Romero; Mariano Valdés; Gregory Y H Lip
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.
European heart journal 2009;30(2):139-51.
2009: Klaus T Preissner; Gregory Y H Lip
Face to face with basic and clinical research in Thrombosis and Haemostasis.
Thrombosis and haemostasis 2009;101(1):1.
2009: Irene Chung; Anirban Choudhury; Jeetesh Patel; Gregory Y H Lip
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Annals of medicine 2009;41(1):45-51.
2008: Eduard Shantsila; Gregory Y H Lip
Predicting thrombotic events: creating a complex approach for a complex condition.
Thrombosis and haemostasis 2008;100(6):962-4.
2008: Kok Hoon Tay; Deirdre Lane; Gregory Y H Lip
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Thrombosis and haemostasis 2008;100(6):955-7.
2008: Kok-Hoon Tay; Gregory Y H Lip
What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?
American journal of hypertension 2008;21(12):1278-9.
2008: Mehmood Butt; Gregory Y H Lip
The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity.
American journal of hypertension 2008;21(12):1275-6.
2008: Gregory Y H Lip; Mehmood Butt
Gender and the response to blood pressure-lowering treatment.
European heart journal 2008;29(21):2585-6.
2008: Naglaa Idriss; Andrew D Blann; Gregory Y H Lip
Hemoxygenase-1 in cardiovascular disease.
Journal of the American College of Cardiology 2008;52(12):971-8.
2008: Michael D Sosin; Jeetesh Patel; Gurbir S Bhatia; Elizabeth A Hughes; Russell C Davis; Gregory Y H Lip
Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure.
International journal of cardiology 2008;129(1):69-75.
2008: Sergio Manzano-Fernández; Francisco Marin; Jose A Hurtado Martinez; Francisco Cambronero; Mariano Valdés; Juan Miguel Ruiz-Nodar; Patricio Pérez-Berbel; Gregory Y H Lip
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.
QJM : monthly journal of the Association of Physicians 2008;101(9):749-51.
2008: Anirban Choudhury; Irene Chung; Nimai Panja; Jeetesh Patel; Gregory Y H Lip
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Chest 2008;134(3):574-81.
2008: Sergio Manzano-Fernández; Francisco J Pastor; Francisco Marin; Francisco Cambronero; Cesar Caro; Domingo A Pascual Figal; Iris P Garrido; Eduardo Pinar; Mariano Valdés; Gregory Y H Lip
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Chest 2008;134(3):559-67.
2008: Sern H Lim; Gregory Y H Lip; John E Sanderson
Ventricular optimization of biventricular pacing: a systematic review.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(8):901-6.
2008: Gregory Y H Lip; Andrew D Blann
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?
Hypertension 2008;52(2):218-9.
2008: Ashan Gunarathne; Jeetesh Patel; Elizabeth A Hughes; Gregory Y H Lip
Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification.
American journal of hypertension 2008;21(8):866-72.
2008: Hoong Sern Lim; Gregory Y H Lip
Asymptomatic atrial fibrillation on device interrogation.
Journal of cardiovascular electrophysiology 2008;19(8):891-3.
2008: Kiat Tsong Tan; Gregory Y H Lip
Imaging of the unstable plaque.
International journal of cardiology 2008;127(2):157-65.
2008: Gregory Y H Lip
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
Thrombosis and haemostasis 2008;100(1):11-3.
2008: Eduard Shantsila; Gregory Y H Lip
Beyond glucose levels in diabetic patients with coronary artery disease: platelet activity and non-responsiveness to antiplatelet therapy.
Thrombosis and haemostasis 2008;100(1):7-8.
2008: Klaus T Preissner; Gregory Y H Lip
Thrombosis and Haemostasis: volume 100 and going strong ...
Thrombosis and haemostasis 2008;100(1):1-2.
2008: Gregory Y H Lip
Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
American heart journal 2008;156(1):1-3.
2008: Philip C Bennett; Deirdre Lane; Gregory Y H Lip
Vital exhaustion and cardiovascular disease: are circulating fibrinogen and D-dimer levels a plausible link?
Stress (Amsterdam, Netherlands) 2008;11(4):247-9.
2008: Vojtech Melenovsky; Gregory Y H Lip
Interleukin-8 and atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(7):784-5.
2008: Timothy Watson; Gregory Y H Lip
Identifying AF patients at risk of stroke: can prothrombotic indices improve things?
International journal of cardiology 2008;126(3):299-301.
2008: Juan M Ruiz Nodar; Francisco Marin; Gregory Y H Lip
Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
JACC. Cardiovascular interventions 2008;1(3):329; author reply 330-1.
2008: Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 2008;133(6 Suppl):546S-592S.
2008: Jeetesh Patel; Shridhar Dwivedi; Elizabeth A Hughes; Gregory Y H Lip
Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder?
Thrombosis and haemostasis 2008;99(6):991-2.
2008: Timothy Watson; Patrick K Y Goon; Gregory Y H Lip
Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.
Antioxidants & redox signaling 2008;10(6):1079-88.
2008: Armen Yuri Gasparyan; Timothy Watson; Gregory Y H Lip
The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
Journal of the American College of Cardiology 2008;51(19):1829-43.
2008: Jean Jacques Blanc; Jesús Almendral; Michele Brignole; Marjaneh Fatemi; Knut Gjesdal; Esteban González-Torrecilla; Piotr Kulakowski; Gregory Y H Lip; Dipen Shah; Christian Wolpert
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(5):513-27.
2008: Jaspal S Taggar; Gregory Y H Lip
Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range.
Current medical research and opinion 2008;24(5):1455-8.
2008: Hoong Sern Lim; Gregory Y H Lip; Hung-Fat Tse
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(5):536-9.
2008: Bethan Freestone; Finn Gustafsson; Aun Yeong Chong; Pernille Corell; Caroline Kistorp; Per Hildebrandt; Gregory Y H Lip
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Chest 2008;133(5):1203-8.
2008: Gregory Y H Lip
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
Stroke; a journal of cerebral circulation 2008;39(5):1406-8.
2008: Caroline Kistorp; Aun Y Chong; Finn Gustafsson; Søren Galatius; Ilan Raymond; Jens Faber; Gregory Y H Lip; Per Hildebrandt
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.
European journal of heart failure 2008;10(4):380-7.
2008: Robby Nieuwlaat; Trang Dinh; S Bertil Olsson; A John Camm; Alessandro Capucci; Robert G Tieleman; Gregory Y H Lip; Harry J G M Crijns
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
European heart journal 2008;29(7):915-22.
2008: Jaspal S Taggar; Francisco Marín; Gregory Y H Lip
Mortality in patients with atrial fibrillation: improving or not?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(4):389-90.
2008: Christopher J Boos; Balu Balakrishnan; Gregory Y H Lip
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.
Journal of thrombosis and thrombolysis 2008;25(2):135-40.
2008: Kate Jolly; Rod S Taylor; Gregory Y H Lip; Sally Singh
Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation.
International journal of cardiology 2008;125(1):144-5.
2008: Gregory Y H Lip
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.
BMJ (Clinical research ed.) 2008;336(7644):614-5.
2008: Vanessa Roldán; Francisco Marín; Gregory Y H Lip
Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass".
Circulation 2008;117(8):e169; author reply e170.
2008: Juan M Ruiz Nodar; Francisco Marin; José Antonio Hurtado; José Valencia; Eduardo Pinar; Javier Pineda; Juan Ramón Gimeno; Francisco Sogorb; Mariano Valdés; Gregory Y H Lip
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Journal of the American College of Cardiology 2008;51(8):818-25.
2008: Eduard Shantsila; Timothy Watson; Hung-Fat Tse; Gregory Y H Lip
New insights on endothelial progenitor cell subpopulations and their angiogenic properties.
Journal of the American College of Cardiology 2008;51(6):669-71.
2008: Puneet Kakar; Timothy Watson; Gregory Y H Lip
New approaches to therapy with omega-3 fatty acids.
Current atherosclerosis reports 2008;10(1):79-87.
2008: Michael Hughes; Gregory Y H Lip
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
Thrombosis and haemostasis 2008;99(2):295-304.
2008: Christopher J Boos; Gregory Y H Lip
Inflammation and atrial fibrillation: cause or effect?
Heart (British Cardiac Society) 2008;94(2):133-4.
2008: Jaspal S Taggar; Timothy Watson; Gregory Y H Lip
Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism?
Stroke; a journal of cerebral circulation 2008;39(2):e24-5; author reply e26.
2008: Gregory Y H Lip; Timothy Watson
Atrial fibrillation (acute onset).
Clinical evidence 2008;2008():.
2008: Jeetesh Patel; Michael D Sosin; Ashan Gunarathne; Imran Hussain; Russell C Davis; Elizabeth A Hughes; Gregory Y H Lip
Elevated angiogenin levels in chronic heart failure.
Annals of medicine 2008;40(6):474-9.
2008: Gregory Y H Lip
Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention.
BMJ (Clinical research ed.) 2008;337():a840.
2008: Olena Dotsenko; Julia Chackathayil; Jeetesh Patel; Paramjit S Gill; Gregory Y H Lip
Candidate circulating biomarkers for the cardiovascular disease continuum.
Current pharmaceutical design 2008;14(24):2445-61.
2008: Eduard Shantsila; Gregory Y H Lip
'Aspirin resistance' or treatment non-compliance: which is to blame for cardiovascular complications?
Journal of translational medicine 2008;6():47.
2008: Andrea Rubboli; Jonathan L Halperin; K E Juhani Airaksinen; Michael Buerke; Eric Eeckhout; Saul B Freedman; Anthony H Gershlick; Axel Schlitt; Hung Fat Tse; Freek W A Verheugt; Gregory Y H Lip
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
Annals of medicine 2008;40(6):428-36.
2008: Vanessa Roldán; Francisco Marin; Rocio González-Conejero; Antonio García-Honrubia; Silvia Martí; Aranzazu Alfaro; Mariano Valdés; Javier Corral; Gregory Y H Lip; Vicente Vicente
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.
Annals of medicine 2008;40(7):553-9.
2008: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Statins and inflammation: reciprocal effectors to endothelial progenitors?
Thrombosis research 2008;123(1):1-4.
2008: Jeetesh Patel; Hoong Sern Lim; George I Varughese; Elizabeth A Hughes; Gregory Y H Lip
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
Annals of medicine 2008;40(3):215-22.
2008: Faekah Gohar; Sheila M Greenfield; D Gareth Beevers; Gregory Y H Lip; Kate Jolly
Self-care and adherence to medication: a survey in the hypertension outpatient clinic.
BMC complementary and alternative medicine 2008;8():4.
2008: Jaspal S Taggar; Gregory Y H Lip
Risk predictors for lone atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(1):6-8.
2008: Jaspal S Taggar; Gregory Y H Lip
The QRISK was less likely to overestimate cardiovascular risk than the Framingham or ASSIGN equations.
ACP journal club 2008;148(1):25.
2008: Hoong Sern Lim; Muzahir H Tayebjee; Kiat T Tan; Jeetesh Patel; Robert J MacFadyen; Gregory Y H Lip
Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
Thrombosis research 2008;122(3):307-13.
2008: Deirdre Lane; Gregory Y H Lip
Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.
Stroke; a journal of cerebral circulation 2008;39(1):7-9.
2008: Bethan Freestone; Aun Yeong Chong; Sarah Nuttall; Gregory Y H Lip
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Thrombosis research 2008;122(1):85-90.
2008: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Cardioversion and remodelling in atrial fibrillation: Insights beyond the prothrombotic state.
Thrombosis research 2008;121(4):443-5.
2008: Christopher J Boos; Balu Balakrishnan; Gregory Y H Lip
The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
Annals of medicine 2008;40(1):66-73.
2008: Jaspal S Taggar; Gregory Y H Lip
Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(1):1-2.
2008: Irene Chung; Anirban Choudhury; Gregory Y H Lip
Platelet adhesion in congestive heart failure.
Thrombosis research 2008;121(6):885-8.
2007: Gregory Y H Lip; Michael Rudolf
Atrial fibrillation: Rate control and digoxin.
BMJ (Clinical research ed.) 2007;335(7631):1169-70.
2007: Christopher J Boos; Balu Balakrishnan; Shahirose Jessani; Andrew D Blann; Gregory Y H Lip
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
Chest 2007;132(6):1920-6.
2007: Anirban Choudhury; Bethan Freestone; Jeetesh Patel; Gregory Y H Lip
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
Chest 2007;132(6):1913-9.
2007: Antonio Tello-Montoliu; Francisco Marin; Jeetesh Patel; Vanessa Roldán; Luis Mainar; Vicente Vicente; Francisco Sogorb; Gregory Y H Lip
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.
European heart journal 2007;28(24):3006-11.
2007: Ali Hamaad; Gregory Y H Lip; Deborah Nicholls; Robert J MacFadyen
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(6):437-44.
2007: Olena Dotsenko; Julia Chackathayil; Gregory Y H Lip
Cardiac biomarkers: myths, facts and future horizons.
Expert review of molecular diagnostics 2007;7(6):693-7.
2007: Christopher J Boos; Deirdre Lane; Manas Karpha; D Gareth Beevers; Ronnie Haynes; Gregory Y H Lip
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension.
Chest 2007;132(5):1540-7.
2007: Gregory Y H Lip
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
The American journal of medicine 2007;120(11):920-2.
2007: Gregory Y H Lip; Hoong Sern Lim
Atrial fibrillation and stroke prevention.
Lancet neurology 2007;6(11):981-93.
2007: Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
Chest 2007;132(5):1532-9.
2007: Paulus Kirchhof; Angelo Auricchio; Jeroen Bax; Harry Crijns; John Camm; Hans-Christoph Diener; Alessandra D'Alessandro; Gerd Hindricks; Stefan Hohnloser; Lukas Kappenberger; Karl-Heinz Kuck; Gregory Y H Lip; Bertil Olsson; Thomas Meinertz; Silvia Priori; Ursula Ravens; Gerhard Steinbeck; Elisabeth Svernhage; Jan Tijssen; Alphons Vincent; Günter Breithardt
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9(11):1006-23.
2007: Paulus Kirchhof; Angelo Auricchio; Jeroen Bax; Harry Crijns; John Camm; Hans-Christoph Diener; Alessandra D'Alessandro; Gerd Hindricks; Stefan Hohnloser; Lukas Kappenberger; Karl-Heinz Kuck; Gregory Y H Lip; Bertil Olsson; Thomas Meinertz; Silvia Priori; Ursula Ravens; Gerhard Steinbeck; Elisabeth Svernhage; Jan Tijssen; Alphons Vincent; Günter Breithardt
Outcome parameters for trials in atrial fibrillation: executive summary.
European heart journal 2007;28(22):2803-17.
2007: Gregory Y H Lip; Timothy Watson
Stroke prevention in atrial fibrillation--things can only get better.
British journal of clinical pharmacology 2007;64(5):575-7.
2007: Jeetesh Patel; Michael D Sosin; Hoong Sern Lim; Irene Chung; Nimai Panja; Russell C Davis; Elizabeth A Hughes; Gregory Y H Lip
Raised leptin concentrations among South Asian patients with chronic heart failure.
International journal of cardiology 2007;122(1):34-40.
2007: Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
A systematic review of the prothrombotic effects of an acute change in posture: a possible mechanism underlying the morning excess in cardiovascular events?
Chest 2007;132(4):1337-47.
2007: Bethan Freestone; Aun Yeong Chong; Sarah Nuttall; Andrew D Blann; Gregory Y H Lip
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Chest 2007;132(4):1253-8.
2007: Timothy Watson; Gregory Y H Lip
Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited.
Stroke; a journal of cerebral circulation 2007;38(10):e107-8.
2007: Graham Thrall; Gregory Y H Lip; Douglas Carroll; Deirdre Lane
Depression, anxiety, and quality of life in patients with atrial fibrillation.
Chest 2007;132(4):1259-64.
2007: Christopher J Boos; Gregory Y H Lip; Bernd Jilma
Endotoxemia, inflammation, and atrial fibrillation.
The American journal of cardiology 2007;100(6):986-8.
2007: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9 Suppl 4():iv37-44.
2007: Vellore J Karthikeyan; Gregory Y H Lip
Alpha 1-microglobulin: a further insight into inflammation in hypertension?
American journal of hypertension 2007;20(9):1022-3.
2007: Patrick K Y Goon; Gregory Y H Lip
Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X.
Heart (British Cardiac Society) 2007;93(9):1020-1.
2007: Miren Jones; Kate Jolly; James Raftery; Gregory Y H Lip; Sheila Greenfield
'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.
Family practice 2007;24(4):343-57.
2007: Patrick K Y Goon; Timothy Watson; Paul S Stonelake; Gregory Y H Lip
The quest for circulating endothelial cell standardization: the peril of platelets.
Cytometry. Part B, Clinical cytometry 2007;72(5):416.
2007: Kate Fletcher; Jonathan Mant; Roger L Holder; David Fitzmaurice; Gregory Y H Lip; F D Richard Hobbs
An analysis of factors that predict patient consent to take part in a randomized controlled trial.
Family practice 2007;24(4):388-94.
2007: David Fitzmaurice; F D Richard Hobbs; Sue Jowett; Jonathan Mant; Ellen T Murray; Roger L Holder; James Raftery; Stirling Bryan; Michael Davies; Gregory Y H Lip; Teresa F Allan
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.
BMJ (Clinical research ed.) 2007;335(7616):383.
2007: Jonathan Mant; David Fitzmaurice; F D Richard Hobbs; Sue Jowett; Ellen T Murray; Roger L Holder; Michael Davies; Gregory Y H Lip
Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
BMJ (Clinical research ed.) 2007;335(7616):380.
2007: Gregory Y H Lip; Hung-Fat Tse
Management of atrial fibrillation.
Lancet 2007;370(9587):604-18.
2007: Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
Lancet 2007;370(9586):493-503.
2007: Timothy Watson; Eduard Shantsila; Gregory Y H Lip
Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
International journal of cardiology 2007;120(1):123-4; author reply 125-6.
2007: Gregory Y H Lip
Coronary artery disease and ischemic stroke in atrial fibrillation.
Chest 2007;132(1):8-10.
2007: Hoong Sern Lim; Gregory Y H Lip
Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?
Lancet neurology 2007;6(7):578-9.
2007: Graham J Caine; Peter Ryan; Gregory Y H Lip; Andrew D Blann
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
Cancer letters 2007;251(2):296-301.
2007: Aun Yeong Chong; Bethan Freestone; Hoong Sern Lim; Caroline Kistorp; Finn Gustafsson; Per Hildebrandt; Gregory Y H Lip
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
International journal of cardiology 2007;119(1):80-2.
2007: Patrick K Y Goon; Timothy Watson; Gregory Y H Lip
Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson.
American journal of respiratory and critical care medicine 2007;175(12):1346; author reply 1347.
2007: J Rumi Jaumdally; Chetan Varma; Gregory Y H Lip
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?
Expert opinion on pharmacotherapy 2007;8(9):1235-43.
2007: Robby Nieuwlaat; S Bertil Olsson; Gregory Y H Lip; A John Camm; Günter Breithardt; Alessandro Capucci; Joan Meeder; Martin H Prins; Samuel Lévy; Harry J G M Crijns
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
American heart journal 2007;153(6):1006-12.
2007: Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; Gregory Y H Lip
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
American journal of hypertension 2007;20(6):699-704.
2007: Shahirose Jessani; Gregory Y H Lip
Physical fitness and the relationship between hypertension and markers of atherothrombosis.
American journal of hypertension 2007;20(6):676-7.
2007: Timothy Watson; Puneet Kakar; Gregory Y H Lip
Cardioversion for atrial fibrillation: does inflammation matter?
The American journal of cardiology 2007;99(11):1617-8.
2007: V J Karthikeyan; Gregory Y H Lip
Statins and intra-plaque angiogenesis in carotid artery disease.
Atherosclerosis 2007;192(2):455-6.
2007: Rumi J Jaumdally; Chetan Varma; Robert J MacFadyen; Gregory Y H Lip
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease.
Journal of thrombosis and thrombolysis 2007;23(3):189-94.
2007: Anirban Choudhury; Irene Chung; Andrew D Blann; Gregory Y H Lip
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Journal of the American College of Cardiology 2007;49(19):1957-64.
2007: Deirdre Lane; Gregory Y H Lip
Maintaining therapeutic anticoagulation: the importance of keeping "within range".
Chest 2007;131(5):1277-9.
2007: Gregory Y H Lip
Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice.
International journal of clinical practice 2007;61(5):714-6.
2007: Puneet Kakar; Gregory Y H Lip
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.
Expert review of cardiovascular therapy 2007;5(3):441-50.
2007: Christopher J Boos; Simren K Soor; Delene Kang; Gregory Y H Lip
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.
European heart journal 2007;28(9):1092-101.
2007: Gregory Y H Lip; Puneet Kakar; Timothy Watson
Atrial fibrillation--the growing epidemic.
Heart (British Cardiac Society) 2007;93(5):542-3.
2007: Victoria Hurley; Rosa Ireson; Kate Fletcher; Gregory Y H Lip; F D Richard Hobbs; Jonathan Mant
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
International journal of cardiology 2007;117(2):152-6.
2007: Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Andrew D Blann
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Cancer letters 2007;248(1):131-6.
2007: Gregory Y H Lip; Timothy Watson
Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.
European heart journal 2007;28(8):926-8.
2007: Rumi Jaumdally; Chetan Varma; Robert J MacFadyen; Gregory Y H Lip
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
European heart journal 2007;28(8):929-40.
2007: Vellore J Karthikeyan; D Gareth Beevers; Gregory Y H Lip
Ethnic disparities in malignant hypertension: further observations.
Journal of hypertension 2007;25(4):895; author reply 896.
2007: Gregory Y H Lip; Jeetesh Patel; Elizabeth Hughes; Robert Hart
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
Stroke; a journal of cerebral circulation 2007;38(4):1229-37.
2007: George I Varughese; Jeetesh Patel; Joseph Tomson; Gregory Y H Lip
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
Heart (British Cardiac Society) 2007;93(4):495-9.
2007: Puneet Kakar; Timothy Watson; Gregory Y H Lip
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.
Current opinion in investigational drugs (London, England : 2000) 2007;8(3):256-65.
2007: Puneet Kakar; Timothy Watson; Gregory Y H Lip
Rivaroxaban.
Drugs of today (Barcelona, Spain : 1998) 2007;43(3):129-36.
2007: Anirban Choudhury; Irene Chung; Andrew D Blann; Gregory Y H Lip
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Chest 2007;131(3):809-15.
2007: Shahirose Jessani; Gregory Y H Lip
Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for?
International journal of clinical practice 2007;61(3):356-8.
2007: Gregory Y H Lip; Lars Frison; Margaretha Grind
Effect of hypertension on anticoagulated patients with atrial fibrillation.
European heart journal 2007;28(6):752-9.
2007: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Endothelial progenitor cells in cardiovascular disorders.
Journal of the American College of Cardiology 2007;49(7):741-52.
2007: Aun Yeong Chong; Gregory Y H Lip
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
European journal of heart failure 2007;9(2):124-8.
2007: Jeetesh Patel; Kaeng W Lee; Joseph Tomson; Kiran Dubb; Elizabeth A Hughes; Gregory Y H Lip
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.
International journal of cardiology 2007;115(1):42-5.
2007: Deepak Goyal; Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients.
International journal of cardiology 2007;114(2):261-4.
2007: Christopher J Boos; Andrew D Blann; Gregory Y H Lip
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.
Methods in molecular medicine 2007;139():211-24.
2007: Jeetesh Patel; Ashan Gunarathne; Deidre Lane; Hoong S Lim; Inessa Tracey; Nimai C Panja; Gregory Y H Lip; Elizabeth A Hughes
Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project.
BMC health services research 2007;7():192.
2007: Samir Srivastava; Gregory Y H Lip
Atherosclerotic renal artery stenosis--do we really know what to do?
Blood pressure 2007;16(5):288-90.
2007: Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.
Annals of medicine 2007;39(8):628-33.
2007: Hoong Sern Lim; Gregory Y H Lip
From diabetes to metabolic syndrome: a viewpoint on an evolving concept.
Current pharmaceutical design 2007;13(25):2580-3.
2007: VJ Karthikeyan; Gregory Y H Lip
Hypertension in pregnancy: pathophysiology and management strategies.
Current pharmaceutical design 2007;13(25):2567-79.
2007: Michael Kühl; Gregory Y H Lip; Chetan Varma
Management of hypertension in relation to acute coronary syndromes and revascularisation.
Current pharmaceutical design 2007;13(25):2556-66.
2007: Patrick K Y Goon; Paul S Stonelake; Gregory Y H Lip
Hypertension, anti-hypertensive therapy and neoplasia.
Current pharmaceutical design 2007;13(25):2539-44.
2007: Eduard Shantsila; Timothy Watson; Hung-Fat Tse; Gregory Y H Lip
Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers?
Annals of medicine 2007;39(6):474-9.
2007: Antonio Tello-Montoliu; Jose-Manuel Molto-Jorda; Nicolás López-Hernández; Ana García-Medina; Vanessa Roldán; Francisco Sogorb; Gregory Y H Lip; Francisco Marin
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes.
Cerebrovascular diseases (Basel, Switzerland) 2007;24(4):338-42.
2007: Patrick Ky Goon; Timothy Watson; Gregory Y H Lip
New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers.
Clinical laboratory 2007;53(5-6):297-9.
2007: Puneet Kakar; Christopher J Boos; Gregory Y H Lip
Management of atrial fibrillation.
Vascular health and risk management 2007;3(1):109-16.
2007: Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
Annals of medicine 2007;39(4):298-305.
2007: Christopher J Boos; Gareth D Beevers; Gregory Y H Lip
Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.
Annals of medicine 2007;39(1):72-8.
2007: Timothy Watson; Eduard Shanstila; Gregory Y H Lip
Modern management of atrial fibrillation.
Clinical medicine (London, England) 2007;7(1):28-34.
2007: Kate Jolly; Rod S Tayor; Gregory Y H Lip; Sheila M Greenfield; Michael K Davies; Russell C Davis; Jonathan Mant; Sally J Singh; Jackie T Ingram; Jane Stubley; Andrew J Stevens
Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial.
BMC cardiovascular disorders 2007;7():9.
2007: Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes.
Thrombosis research 2007;120(6):819-47.
2007: Irene Chung; Anirban Choudhury; Gregory Y H Lip
Platelet activation in acute, decompensated congestive heart failure.
Thrombosis research 2007;120(5):709-13.
2007: Anirban Choudhury; Irene Chung; Andrew D Blann; Gregory Y H Lip
Platelet adhesion in atrial fibrillation.
Thrombosis research 2007;120(4):623-9.
2007: Gregory Y H Lip; Michael Rudolf; Puneet Kakar
Management of atrial fibrillation: the NICE guidelines.
International journal of clinical practice 2007;61(1):9-11.
2007: Timothy Watson; Puneet Kakar; Gregory Y H Lip
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
International journal of clinical practice 2007;61(1):6-9.
2007: Christopher J Boos; Gregory Y H Lip
Assessment of mean platelet volume in coronary artery disease - what does it mean?
Thrombosis research 2007;120(1):11-3.
2007: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Aspirin resistance: what, why and when?
Thrombosis research 2007;119(5):551-4.
2006: Puneet Kakar; Ashan Gunarathne; Gregory Y H Lip
Stroke: ethnic differences do exist.
Expert review of neurotherapeutics 2006;6(12):1769-71.
2006: Timothy Watson; Gregory Y H Lip
Management of atrial fibrillation.
Herz 2006;31(9):849-56.
2006: Gregory Y H Lip; Manas Karpha
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Chest 2006;130(6):1823-7.
2006: Robby Nieuwlaat; Alessandro Capucci; Gregory Y H Lip; S Bertil Olsson; Martin H Prins; Fred H M Nieman; José López-Sendón; Panos E Vardas; Etienne Aliot; Massimo Santini; Harry J G M Crijns
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
European heart journal 2006;27(24):3018-26.
2006: Puneet Kakar; Deirdre Lane; Gregory Y H Lip
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema.
Chest 2006;130(5):1296-9.
2006: Irene Chung; Gregory Y H Lip
Platelets and heart failure.
European heart journal 2006;27(22):2623-31.
2006: Christopher J Boos; Gregory Y H Lip; Andrew D Blann
Circulating endothelial cells in cardiovascular disease.
Journal of the American College of Cardiology 2006;48(8):1538-47.
2006: Ali Hamaad; W Kaeng Lee; Gregory Y H Lip; Robert J MacFadyen
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(5):359-64.
2006: Puneet Kakar; Gregory Y H Lip
Atrial fibrillation and stroke prevention.
Expert review of neurotherapeutics 2006;6(10):1523-30.
2006: Shahirose Jessani; Gregory Y H Lip
Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers.
Journal of cardiac failure 2006;12(8):641-3.
2006: Patrick K Y Goon; Gregory Y H Lip
Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.
Journal of thrombosis and thrombolysis 2006;22(2):155-6.
2006: Christopher J Boos; Deirdre Lane; Delene Kang; Patrick K Y Goon; Andrew D Blann; Gregory Y H Lip
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.
Journal of thrombosis and thrombolysis 2006;22(2):125-31.
2006: Christopher J Boos; Gregory Y H Lip
C-reactive protein and lone atrial fibrillation: potential confounders.
The American journal of cardiology 2006;98(7):991-2.
2006: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
American journal of hypertension 2006;19(9):970-7; discussion 978.
2006: Vellore J Karthikeyan; Gregory Y H Lip
Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system?
Journal of hypertension 2006;24(9):1715-7.
2006: Gregory Y H Lip; Deirdre Lane; Carl van Walraven; Robert Hart
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.
Stroke; a journal of cerebral circulation 2006;37(9):2294-300.
2006: Kate Jolly; Rod S Taylor; Gregory Y H Lip; Andrew J Stevens
Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.
International journal of cardiology 2006;111(3):343-51.
2006: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
International journal of cardiology 2006;111(2):302-8.
2006: Patrick K Y Goon; Gregory Y H Lip
Arterial disease and venous thromboembolism: a modern paradigm?
Thrombosis and haemostasis 2006;96(2):111-2.
2006: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Atrial fibrillation post-cardiac surgery: changing perspectives.
Current medical research and opinion 2006;22(8):1437-41.
2006: Gregory Y H Lip; Antonio Tello-Montoliu
Management of atrial fibrillation.
Heart (British Cardiac Society) 2006;92(8):1177-82.
2006: Gregory Y H Lip; Timothy Watson; Eduard Shantsila
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
European heart journal 2006;27(16):1893-4.
2006: Gregory Y H Lip
Antithrombotic therapy: standard therapy in essential hypertension?
Progress in cardiovascular diseases 2006;49(1):11-5.
2006: Patrick K Y Goon; Christopher J Boos; Paul S Stonelake; Andrew D Blann; Gregory Y H Lip
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
Thrombosis and haemostasis 2006;96(1):45-52.
2006: Gregory Y H Lip
Aspirin for prevention of stroke in atrial fibrillation.
Stroke; a journal of cerebral circulation 2006;37(7):1640.
2006: Deirdre Lane; Jennie Ponsford; Alison Shelley; Anu Sirpal; Gregory Y H Lip
Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project.
International journal of cardiology 2006;110(3):354-8.
2006: Vanessa Roldán; Francisco Marin; Amaya García; Antonio Tello-Montoliu; Gregory Y H Lip
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?
International journal of cardiology 2006;110(2):265-6.
2006: Timothy Watson; Eduard Shantsila; Gregory Y H Lip
Pharmacotherapy for atrial fibrillation: is rhythm control achievable?
Expert opinion on pharmacotherapy 2006;7(9):1105-7.
2006: Deirdre Lane; Christopher J Boos; Gregory Y H Lip
Anticoagulation control with vitamin K antagonists: how well are we doing?
Chest 2006;129(5):1122-4.
2006: Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
Quality of life in patients with atrial fibrillation: a systematic review.
The American journal of medicine 2006;119(5):448.e1-19.
2006: Christopher J Boos; Gregory Y H Lip
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
American journal of hypertension 2006;19(5):511-2.
2006: Kiat T Tan; Gregory Y H Lip
Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.
Current treatment options in cardiovascular medicine 2006;8(3):251-8.
2006: Antonio Tello-Montoliu; Vanessa Roldán; Vicente Climent; Francisco Sogorb; Gregory Y H Lip; Francisco Marin
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?
Journal of thrombosis and thrombolysis 2006;21(2):163-6.
2006: Vicente Climent; Antonio Picó; Francisco Sogorb; Silvia Aznar; Gregory Y H Lip; Francisco Marin
Growth hormone therapy and the heart.
The American journal of cardiology 2006;97(7):1097-102.
2006: Jan Heeringa; Deirdre A M van der Kuip; Albert Hofman; Jan A Kors; Gerard van Herpen; Bruno H Ch Stricker; Theo Stijnen; Gregory Y H Lip; Jacqueline C M Witteman
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.
European heart journal 2006;27(8):949-53.
2006: Gurbir S Bhatia; Michael D Sosin; Jeetesh Patel; Karl A Grindulis; Fazal H Khattak; Elizabeth A Hughes; Gregory Y H Lip; Russell C Davis
Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?
Journal of the American College of Cardiology 2006;47(6):1169-74.
2006: Gregory Y H Lip
Viewpoint.
Circulation 2006;113(9):f33-4.
2006: Timothy Watson; Gregory Y H Lip
Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
International journal of clinical practice 2006;60(3):252-5.
2006: Aun Yeong Chong; Bethan Freestone; Jeetesh Patel; Hoong Sern Lim; Elizabeth Hughes; Andrew D Blann; Gregory Y H Lip
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
The American journal of cardiology 2006;97(5):671-5.
2006: Aun Yeong Chong; Gregory Y H Lip; Bethan Freestone; Andrew D Blann
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
European journal of heart failure 2006;8(2):167-72.
2006: Christopher J Boos; Gregory Y H Lip
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
Journal of the American College of Cardiology 2006;47(4):889-90; author reply 890-1.
2006: Ali Hamaad; Angie Ghattas; Fatima Hirani; Gregory Y H Lip; Robert J MacFadyen
Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk.
International journal of cardiology 2006;107(2):235-40.
2006: Germanas Marinskis; Gregory Y H Lip; Audrius Aidietis; Audrius Adietis; Paulius Jurkuvenas; Diana Kaireviciūte; Vladimir Jezov; Kestutis Bagdonas; Pranas Serpytis; Aleksandras Laucevicius
Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias.
International journal of cardiology 2006;107(1):134-5.
2006: V J Karthikeyan; Gregory Y H Lip
Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation.
Evidence-based medicine 2006;11(1):15.
2006: VJ Karthikeyan; Gregory Y H Lip
Blood pressure control and prevention of stroke.
Expert review of neurotherapeutics 2006;6(2):203-12.
2006: V J Karthikeyan; Gregory Y H Lip
Pulse pressure and carotid atherosclerosis: an important link revisited?
International journal of clinical practice 2006;60(2):127-30.
2006: V J Karthikeyan; Gregory Y H Lip
Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction?
The Tohoku journal of experimental medicine 2006;208(2):93-7.
2006: Christopher J Boos; Gregory Y H Lip
Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):e18.
2006: Simon L Bacon; Christopher Ring; Foo Li Saw Hee; Gregory Y H Lip; Andrew D Blann; Kim L Lavoie; Douglas Carroll
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.
Biological psychology 2006;71(2):162-70.
2006: Andrew D Blann; Gregory Y H Lip
Venous thromboembolism.
BMJ (Clinical research ed.) 2006;332(7535):215-9.
2006: Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Anticoagulation for stroke prevention: high effectiveness, more cost benefit?
PharmacoEconomics 2006;24(10):1035-8.
2006: Jeetesh Patel; David E Cummings; John P Girod; Alwin V Mascarenhas; Elizabeth A Hughes; Manjula Gupta; Gregory Y H Lip; Sethu Reddy; Daniel J Brotman
Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.
Journal of negative results in biomedicine 2006;5():14.
2006: Christopher J Boos; Gregory Y H Lip
Is hypertension an inflammatory process?
Current pharmaceutical design 2006;12(13):1623-35.
2006: J Rumi Jaumdally; Gregory Y H Lip; Chetan Varma
Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal.
Current pharmaceutical design 2006;12(13):1611-21.
2006: George I Varughese; Jeetesh Patel; Gregory Y H Lip; Chetan Varma
Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.
Current pharmaceutical design 2006;12(13):1593-609.
2006: Sunil Nadar; Muzahir H Tayebjee; Franz Messerli; Gregory Y H Lip
Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Current pharmaceutical design 2006;12(13):1581-92.
2006: Hoong Sern Lim; Robert J MacFadyen; George L Bakris; Gregory Y H Lip
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.
Current pharmaceutical design 2006;12(13):1567-79.
2006: Christopher J Boos; Gregory Y H Lip
Ximelagatran: an eulogy.
Thrombosis research 2006;118(3):301-4.
2006: Muzahir H Tayebjee; Gregory Y H Lip; Kiat T Tan; Robert J MacFadyen
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.
Thrombosis and haemostasis 2006;95(1):202-4.
2006: Anirban Choudhury; Deepak Goyal; Gregory Y H Lip
Ximelagatran.
Drugs of today (Barcelona, Spain : 1998) 2006;42(1):3-19.
2006: Christopher J Boos; Patrick K Y Goon; Gregory Y H Lip
The endothelium, inflammation, and coagulation in sepsis.
Clinical pharmacology and therapeutics 2006;79(1):20-2.
2006: Francisco Marín; Domingo A Pascual; Vanessa Roldán; José María Arribas; Miguel Ahumada; Pedro Luis Tornel; Clara Oliver; Jesús Gómez Plana; Gregory Y H Lip; Mariano Valdés
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
The American journal of cardiology 2006;97(1):55-60.
2006: Bethan Freestone; Aun Yeong Chong; Andrew D Blann; Gregory Y H Lip
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
Thrombosis research 2006;118(4):479-85.
2006: Christopher J Boos; Richard A Anderson; Gregory Y H Lip
Is atrial fibrillation an inflammatory disorder?
European heart journal 2006;27(2):136-49.
2006: Gregory Y H Lip; Chetan Varma
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
Thrombosis research 2006;118(4):429-32.
2006: Gregory Y H Lip; Steven J Edwards
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Thrombosis research 2006;118(3):321-33.
2006: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.
Thrombosis research 2006;118(3):305-12.
2006: Chetan Varma; Gregory Y H Lip
Failed reperfusion with thrombolysis--the effect of a local environment?
Thrombosis research 2006;118(2):185-7.
2006: Graham Thrall; Deirdre Lane; Gregory Y H Lip
Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.
Thrombosis research 2006;117(3):351-2.
2006: Daniel J Brotman; John P Girod; Amy Posch; Jayesh T Jani; Jeetesh Patel; Manjula Gupta; Gregory Y H Lip; Sethu Reddy; Thomas S Kickler
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.
Thrombosis research 2006;118(2):247-52.
2006: Gregory Y H Lip; Bethan Freestone
Cardioversion and the endothelium in atrial fibrillation.
Thrombosis research 2006;117(3):231-3.
2005: Christopher J Boos; Patrick K Y Goon; Gregory Y H Lip
Circulating endothelial progenitor cells.
The New England journal of medicine 2005;353(24):2613-6; author reply 2613-6.
2005: Gregory Y H Lip; George I Varughese
Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.
International journal of cardiology 2005;105(3):319-21.
2005: Gregory Y H Lip
Atrial fibrillation (recent onset).
Clinical evidence 2005;(14):71-89.
2005: Ali Hamaad; Michael D Sosin; Andrew D Blann; Jeetesh Patel; Gregory Y H Lip; Robert J MacFadyen
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.
Clinical cardiology 2005;28(12):570-6.
2005: Christopher J Boos; Gregory Y H Lip
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect.
Journal of thrombosis and thrombolysis 2005;20(3):189-90.
2005: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
Thrombosis and haemostasis 2005;94(5):1077-83.
2005: Sunil Nadar; Ioannis Karalis; Eman Al Yemeni; Andrew D Blann; Gregory Y H Lip
Plasma markers of angiogenesis in pregnancy induced hypertension.
Thrombosis and haemostasis 2005;94(5):1071-6.
2005: Gregory Y H Lip; Christopher J Boos
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(11):2240-2.
2005: Dirk C Felmeden; Gregory Y H Lip
Endothelial function and its assessment.
Expert opinion on investigational drugs 2005;14(11):1319-36.
2005: Gurbir S Bhatia; Michael D Sosin; Fazal H Khattak; Russell C Davis; Gregory Y H Lip
Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology.
International journal of cardiology 2005;105(1):1-10.
2005: Sunil Nadar; Gregory Y H Lip; Kaeng W Lee; Andrew D Blann
Circulating endothelial cells in acute ischaemic stroke.
Thrombosis and haemostasis 2005;94(4):707-12.
2005: Bethan Freestone; Gregory Y H Lip; Aun Yeong Chong; Sunil Nadar; Kaeng W Lee; Andrew D Blann
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Thrombosis and haemostasis 2005;94(4):702-6.
2005: Anirban Choudhury; George I Varughese; Gregory Y H Lip
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
Expert opinion on pharmacotherapy 2005;6(13):2193-207.
2005: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.
American heart journal 2005;150(4):756-66.
2005: Kiat T Tan; Gregory Y H Lip
The potential role of platelet microparticles in atherosclerosis.
Thrombosis and haemostasis 2005;94(3):488-92.
2005: Kiat T Tan; Muzahir H Tayebjee; Robert J MacFadyen; Gregory Y H Lip; Andrew D Blann
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Platelets 2005;16(6):368-71.
2005: Sam Schulman; Gregory Y H Lip
Ximelagatran in the clinic: practical management of patients.
Seminars in vascular medicine 2005;5(3):301-7.
2005: Hoong Sern Lim; Gregory Y H Lip
Interleukin-15 in hypertension: further insights into inflammation and vascular disease.
American journal of hypertension 2005;18(8):1017-8.
2005: Joseph Tomson; Gregory Y H Lip
Blood pressure changes in acute haemorrhagic stroke.
Blood pressure monitoring 2005;10(4):197-9.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Kiat T Tan; Jeetesh Patel; Elizabeth A Hughes; Robert J MacFadyen
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
The American journal of cardiology 2005;96(3):339-45.
2005: Christopher J Boos; Gregory Y H Lip
The role of inflammation in atrial fibrillation.
International journal of clinical practice 2005;59(8):870-2.
2005: Kiat T Tan; Muzahir H Tayebjee; Robert J MacFadyen; Gregory Y H Lip
Relation of platelet activation to coronary angiographic severity and collateralization.
The American journal of cardiology 2005;96(2):208-10.
2005: Christopher J Boos; Gregory Y H Lip
Ximelagatran for stroke prevention in atrial fibrillation.
Expert review of cardiovascular therapy 2005;3(4):551-63.
2005: Deirdre Lane; Gregory Y H Lip; D Gareth Beevers
Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project.
Journal of hypertension 2005;23(7):1347-53.
2005: George I Varughese; Gregory Y H Lip
Is hypertension a prothrombotic state?
Current hypertension reports 2005;7(3):168-73.
2005: Daniel J Brotman; John P Girod; Mario J. Garcia; Jeetesh Patel; Manjula Gupta; Amy Posch; Sue Saunders; Gregory Y H Lip; Sarah Worley; Sethu Reddy
Effects of short-term glucocorticoids on cardiovascular biomarkers.
The Journal of clinical endocrinology and metabolism 2005;90(6):3202-8.
2005: Muzahir H Tayebjee; Gregory Y H Lip
Heterotopic heart transplantation.
International journal of cardiology 2005;101(2):311-2.
2005: Ali Hamaad; Michael D Sosin; Gregory Y H Lip; Robert J MacFadyen
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(3):183-7.
2005: Gregory Y H Lip; Irene Chung
Vascular endothelial growth factor and angiogenesis in heart failure.
Journal of cardiac failure 2005;11(4):285-7.
2005: Hoong Sern Lim; Gregory Y H Lip; Andrew D Blann
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Atherosclerosis 2005;180(1):113-8.
2005: Caroline Schmidt-Lucke; Funmi M Belgore; Dirk Reinhold; Siegfried Ansorge; Helmut U Klein; J André Schmidt-Lucke; Gregory Y H Lip
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.
International journal of cardiology 2005;100(2):207-12.
2005: Francisca López; Kaeng W Lee; Francisco Marín; Vanessa Roldán; Francisco Sogorb; Juan Caturla; Gregory Y H Lip
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain.
International journal of cardiology 2005;100(1):151-4.
2005: Hoong Sern Lim; Jeetesh Patel; Sunil Nadar; Elizabeth A Hughes; Gregory Y H Lip
Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.
The American journal of cardiology 2005;95(7):905-8.
2005: Vanessa Roldán; Francisco Marin; Juan G Martínez; Ana García-Herola; Francisco Sogorb; Gregory Y H Lip
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.
The American journal of cardiology 2005;95(7):881-2.
2005: Sunil Nadar; Neeraj Prasad; Rod S Taylor; Gregory Y H Lip
Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis.
International journal of cardiology 2005;99(2):171-85.
2005: Dwayne S G Conway; Gregory Y H Lip
Atrial fibrillation, the prothrombotic state, inflammation, and gender.
The American journal of cardiology 2005;95(6):819.
2005: Deepak Goyal; Robert J MacFadyen; Robert D Watson; Gregory Y H Lip
Ambulatory blood pressure monitoring in heart failure: a systematic review.
European journal of heart failure 2005;7(2):149-56.
2005: Muzahir H Tayebjee; Ioannis Karalis; Sunil Nadar; D Gareth Beevers; Robert J MacFadyen; Gregory Y H Lip
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
American journal of hypertension 2005;18(3):325-9.
2005: George I Varughese; Gregory Y H Lip
Goodbye mercury? Blood pressure measurement and its future.
Journal of the Royal Society of Medicine 2005;98(3):89-90.
2005: Andrew D Blann; Kiat T Tan; Muzahir H Tayebjee; Indran Davagnanam; Mark Moss; Gregory Y H Lip
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Thrombosis and haemostasis 2005;93(3):578-83.
2005: Andrew D Blann; Alexander Woywodt; Francesco Bertolini; Todd M Bull; Jill P Buyon; Robert M Clancy; Marion Haubitz; Robert P Hebbel; Gregory Y H Lip; Patrizia Mancuso; Jose Sampol; Anna Solovey; Françoise Dignat-George
Circulating endothelial cells. Biomarker of vascular disease.
Thrombosis and haemostasis 2005;93(2):228-35.
2005: Deepak Goyal; Anirban Choudhury; Gregory Y H Lip
Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies.
Current opinion in obstetrics & gynecology 2005;17(1):13-20.
2005: Graham Thrall; Gregory Y H Lip
Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?
Arteriosclerosis, thrombosis, and vascular biology 2005;25(2):265-6.
2005: Hoong Sern Lim; Dirk Felmeden; Gregory Y H Lip
Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins.
Hypertension 2005;45(2):e3.
2005: M Bilal Iqbal; Anil K Taneja; Gregory Y H Lip; Marcus Flather
Recent developments in atrial fibrillation.
BMJ (Clinical research ed.) 2005;330(7485):238-43.
2005: Kaeng W Lee; Gregory Y H Lip; Muzahir H Tayebjee; William Foster; Andrew D Blann
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.
Blood 2005;105(2):526-32.
2005: Francisco Marin; Rocio González-Conejero; Kaeng W Lee; Javier Corral; Vanessa Roldán; Francisca López; Francisco Sogorb; Juan Caturla; Gregory Y H Lip; Vicente Vicente
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Journal of the American College of Cardiology 2005;45(1):25-9.
2005: Kiat T Tan; Gregory Y H Lip
The assessment of platelet activation in antiplatelet drug development.
Current medicinal chemistry 2005;12(26):3117-25.
2005: Bethan Freestone; Aun Yeong Chong; Hoong Sern Lim; Andrew D Blann; Gregory Y H Lip
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Annals of medicine 2005;37(5):365-72.
2005: Ioannis Karalis; Sunil Nadar; Eman Al Yemeni; Andrew D Blann; Gregory Y H Lip
Platelet activation in pregnancy-induced hypertension.
Thrombosis research 2005;116(5):377-83.
2005: Vanessa Roldán; Francisco Marin; Ana García-Herola; Gregory Y H Lip
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
Thrombosis research 2005;116(4):321-5.
2005: Gregory Y H Lip; Irene Chung
Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
Thrombosis research 2005;116(4):275-7.
2005: Joseph Tomson; Gregory Y H Lip
Peripheral arterial disease: a high risk - but neglected - disease population.
BMC cardiovascular disorders 2005;5(1):15.
2005: Aun Yeong Chong; Bernard S P Chin; Andrew D Blann; Gregory Y H Lip
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
Thrombosis research 2005;116(2):181-3.
2005: Kiat T Tan; Muzahir H Tayebjee; Cheryl Lynd; Andrew D Blann; Gregory Y H Lip
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Annals of medicine 2005;37(1):61-6.
2005: Sunil Nadar; Graham J Caine; Andrew D Blann; Gregory Y H Lip
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.
Annals of medicine 2005;37(1):55-60.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.
Current medicinal chemistry 2005;12(8):917-25.
2005: Joseph Tomson; Ingrid Os; Gregory Y H Lip
Hormone replacement use and cardiovascular function and structure in postmenopausal women.
Blood pressure 2005;14(1):3-5.
2005: Gregory Y H Lip
Preventing stroke in atrial fibrillation: the SPORTIF programme.
Pathophysiology of haemostasis and thrombosis 2005;34 Suppl 1():25-30.
2005: Kiat T Tan; Gregory Y H Lip
Fondaparinux.
Current pharmaceutical design 2005;11(4):415-9.
2005: Gurbir S Bhatia; Michael D Sosin; John F Leahy; Derek L Connolly; Russell C Davis; Gregory Y H Lip
Hibernating myocardium in heart failure.
Expert review of cardiovascular therapy 2005;3(1):111-22.
2005: Gurbir S Bhatia; Michael D Sosin; Karl A Grindulis; Russell C Davis; Gregory Y H Lip
Rheumatoid disease and the heart: from epidemiology to echocardiography.
Expert opinion on investigational drugs 2005;14(1):65-76.
2005: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
American journal of hypertension 2005;18(1):104-15.
2005: Joseph Tomson; Gregory Y H Lip
Blood pressure demographics: nature or nurture ... ... genes or environment?
BMC medicine 2005;3():3.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Andrew D Blann; Robert J MacFadyen
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Thrombosis research 2005;115(3):205-10.
2005: Graham Thrall; Gregory Y H Lip
Haemoconcentration and the hypercoagulable state associated with mental stress.
Thrombosis research 2005;115(3):171-3.
2005: Deirdre Lane; Gregory Y H Lip
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Age and ageing 2005;34(1):1-3.
2004: Gurbir S Bhatia; Gregory Y H Lip
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.
Current heart failure reports 2004;1(4):149-55.
2004: Gregory Y H Lip; Peter M Rothwell; Cathie Sudlow
Stroke prevention.
Clinical evidence 2004;(12):253-84.
2004: Sunil Nadar; Gregory Y H Lip; Andrew D Blann
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.
Thrombosis and haemostasis 2004;92(6):1342-8.
2004: Christopher J Boos; Gregory Y H Lip
Novel therapies for the prevention of stroke.
Expert opinion on investigational drugs 2004;13(12):1615-30.
2004: Hoong Sern Lim; Andrew D Blann; Aun Yeong Chong; Bethan Freestone; Gregory Y H Lip
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Diabetes care 2004;27(12):2918-24.
2004: Michael D Sosin; Gurbir S Bhatia; Russell C Davis; Gregory Y H Lip
Heart failure--the importance of ethnicity.
European journal of heart failure 2004;6(7):831-43.
2004: Hoong Sern Lim; Gregory Y H Lip; Andrew D Blann
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.
The Journal of clinical endocrinology and metabolism 2004;89(11):5377-81.
2004: Kaeng W Lee; Gregory Y H Lip; Andrew D Blann
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Circulation 2004;110(16):2355-60.
2004: Francisco Marin; Vanessa Roldán; Antonio Tello; Gregory Y H Lip
Genetic polymorphisms and thromoembolic risk in atrial fibrillation.
Journal of thrombosis and thrombolysis 2004;18(2):151-2.
2004: Ali Hamaad; Gregory Y H Lip; Robert J MacFadyen
Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?
European journal of heart failure 2004;6(6):683-6.
2004: Dwayne S G Conway; Gregory Y H Lip
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation.
European heart journal 2004;25(19):1761.
2004: Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
The unifying role of matrix metalloproteinases in atheroma and vascular stroke.
Stroke; a journal of cerebral circulation 2004;35(10):2239.
2004: Aun Yeong Chong; Andrew D Blann; Jeetesh Patel; Bethan Freestone; Elizabeth Hughes; Gregory Y H Lip
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Circulation 2004;110(13):1794-8.
2004: Hoong Sern Lim; Robert J MacFadyen; Gregory Y H Lip
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.
Archives of internal medicine 2004;164(16):1737-48.
2004: Dwayne S G Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.
American heart journal 2004;148(3):462-6.
2004: G Patrick Clagett; Michael Sobel; Mark R Jackson; Gregory Y H Lip; Marco Tangelder; Raymond Verhaeghe
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):609S-626S.
2004: Muzahir H Tayebjee; Sunil Nadar; Robert J MacFadyen; Gregory Y H Lip
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
American journal of hypertension 2004;17(9):770-4.
2004: Muzahir H Tayebjee; Sunil Nadar; Andrew D Blann; D Gareth Beevers; Robert J MacFadyen; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
American journal of hypertension 2004;17(9):764-9.
2004: Francisco Marín; Javier Corral; Vanessa Roldán; Rocio González-Conejero; María Luz del Rey; Francisco Sogorb; Gregory Y H Lip; Vicente Vicente
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Journal of molecular and cellular cardiology 2004;37(3):699-704.
2004: Anirban Choudhury; Gregory Y H Lip
Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management.
Age and ageing 2004;33(5):434-6.
2004: Graham J Caine; Sunil Nadar; Gregory Y H Lip; Paul S Stonelake; Andrew D Blann
Platelet adhesion in breast cancer: development and application of a novel assay.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(6):513-8.
2004: Kaeng W Lee; Ali Hamaad; Robert J MacFadyen; Gregory Y H Lip
Effects of dietary fat intake in sudden death: reduction of death with omega-3 fatty acids.
Current cardiology reports 2004;6(5):371-8.
2004: Dwayne S G Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.
The American journal of cardiology 2004;94(4):508-10.
2004: Hoong Sern Lim; Ali Hamaad; Gregory Y H Lip
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.
Critical care (London, England) 2004;8(4):271-9.
2004: Michael D Sosin; Gurbir S Bhatia; John Zarifis; Russell C Davis; Gregory Y H Lip
An 8-year follow-up study of acute admissions with heart failure in a multiethnic population.
European journal of heart failure 2004;6(5):669-72.
2004: Muzahir H Tayebjee; H Sern Lim; Robert J MacFadyen; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.
Diabetes care 2004;27(8):2049-51.
2004: Deepak Goyal; Anirban Choudhary; Gregory Y H Lip; Robert J MacFadyen
Diastolic heart failure: recognition, diagnosis and management.
Expert opinion on pharmacotherapy 2004;5(8):1745-54.
2004: D Gareth Beevers; Gregory Y H Lip; Andrew D Blann
Salt intake and Helicobacter pylori infection.
Journal of hypertension 2004;22(8):1475-7.
2004: Hoong Sern Lim; Jeetesh Patel; Gregory Y H Lip
Metabolic syndrome: a definition in progress.
Circulation 2004;110(4):e35; author reply e35.
2004: Sunil Nadar; Andrew D Blann; Sridhar Kamath; D Gareth Beevers; Gregory Y H Lip
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of the American College of Cardiology 2004;44(2):415-22.
2004: Graham J Caine; Gregory Y H Lip; Paul S Stonelake; Peter Ryan; Andrew D Blann
Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma.
Thrombosis and haemostasis 2004;92(1):185-90.
2004: Anirban Choudhury; Gregory Y H Lip
Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility.
Expert opinion on investigational drugs 2004;13(7):841-55.
2004: Dwayne S G Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
Journal of the American College of Cardiology 2004;43(11):2075-82.
2004: Bethan Freestone; Gregory Y H Lip
Atrial fibrillation (acute).
Clinical evidence 2004;(11):76-97.
2004: Dwayne S G Conway; Gregory Y H Lip
Further insights into the prothrombotic state in mitral stenosis and atrial flutter.
Chest 2004;125(6):2361-2; author reply 2362-3.
2004: Dwayne S G Conway; Gregory Y H Lip
Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project).
The American journal of cardiology 2004;93(11):1422-5, A10.
2004: Dwayne S G Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation.
The American journal of cardiology 2004;93(11):1368-73, A6.
2004: Hoong Sern Lim; Andrew D Blann; Gregory Y H Lip
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Circulation 2004;109(21):2524-8.
2004: Deirdre Lane; Gregory Y H Lip; Douglas Carroll
Is depression following acute myocardial infarction an independent risk for mortality?
The American journal of cardiology 2004;93(10):1333-4.
2004: Sunil Nadar; Gregory Y H Lip
Platelet activation in the hypertensive disorders of pregnancy.
Expert opinion on investigational drugs 2004;13(5):523-9.
2004: Charles G C Spencer; Steven C Martin; Dirk C Felmeden; Andrew D Blann; Gareth D Beevers; Gregory Y H Lip
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
International journal of cardiology 2004;94(2-3):293-300.
2004: Andrew J Makin; Andrew D Blann; Natali A Y Chung; Stanley H Silverman; Gregory Y H Lip
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
European heart journal 2004;25(5):371-6.
2004: Kaeng W Lee; Gregory Y H Lip
Acute versus habitual exercise, thrombogenesis and exercise intensity.
Thrombosis and haemostasis 2004;91(3):416-9.
2004: William Foster; Gregory Y H Lip
Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter?
British journal of haematology 2004;124(6):836-40.
2004: Aun Yeong Chong; Graham J Caine; Bethan Freestone; Andrew D Blann; Gregory Y H Lip
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Journal of the American College of Cardiology 2004;43(3):423-8.
2004: Bethan Freestone; Gregory Y H Lip
Tedisamil: a new novel antiarrhythmic.
Expert opinion on investigational drugs 2004;13(2):151-60.
2004: Daniel J Brotman; Steven R Deitcher; Gregory Y H Lip; Axel C Matzdorff
Virchow's triad revisited.
Southern medical journal 2004;97(2):213-4.
2004: Simon L Bacon; Christopher Ring; Gregory Y H Lip; Douglas Carroll
Increases in lipids and immune cells in response to exercise and mental stress in patients with suspected coronary artery disease: effects of adjustment for shifts in plasma volume.
Biological psychology 2004;65(3):237-50.
2004: Martin J Landray; David C Wheeler; Gregory Y H Lip; David Newman; Andrew D Blann; Fiona J McGlynn; Simon Ball; Jonathan N Townend; Colin Baigent
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):244-53.
2004: Francisco Marín; Vanessa Roldán; Vicente Climent; Gregory Y H Lip
Matrix metalloproteinases in atrial fibrillation.
Journal of the American College of Cardiology 2004;43(1):152; author reply 152-3.
2004: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Antihypertensive therapy and endothelial function.
Current pharmaceutical design 2004;10(29):3607-14.
2004: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Endothelial dysfunction: methods of assessment and application to hypertension.
Current pharmaceutical design 2004;10(29):3591-605.
2004: Michael D Sosin; Gurbir S Bhatia; Gregory Y H Lip; Russell C Davis
Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension.
Current pharmaceutical design 2004;10(29):3569-77.
2004: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
Annals of medicine 2004;36(7):552-7.
2004: Ali Hamaad; Gregory Y H Lip; Robert J MacFadyen
Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease.
Annals of medicine 2004;36(6):448-61.
2004: Gregory Y H Lip; Andrew D Blann
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
Annals of medicine 2004;36(2):119-25.
2004: Sunil Nadar; Eman Al Yemeni; Andrew D Blann; Gregory Y H Lip
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Thrombosis research 2004;113(2):123-8.
2004: Michael D Sosin; Russell C Davis; Gregory Y H Lip
Mortality in congestive heart failure complicated by atrial fibrillation.
European heart journal 2004;25(1):97-8; author reply 98.
2003: Dwayne S G Conway; Gregory Y H Lip
Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project).
The American journal of cardiology 2003;92(12):1476-9.
2003: Hoong Sern Lim; Gregory Y H Lip
Is angiotensin receptor blockade antithrombotic?
Archives of internal medicine 2003;163(22):2790-1; author reply 2792-3.
2003: Bethan Freestone; Gregory Y H Lip; Peter M Rothwell; Cathie Sudlow
Stroke prevention.
Clinical evidence 2003;(10):246-72.
2003: Bethan Freestone; Gregory Y H Lip
Atrial fibrillation (acute).
Clinical evidence 2003;(10):76-94.
2003: Kiat T Tan; Gregory Y H Lip
Atrial fibrillation: should we target platelets or the coagulation pathway?
Cardiac electrophysiology review 2003;7(4):370-1.
2003: Irene Chung; Gregory Y H Lip
White coat hypertension: not so benign after all?
Journal of human hypertension 2003;17(12):807-9.
2003: Fernando Alfonso; Muzahir H Tayebjee; Gregory Y H Lip
Restenosis after coronary stenting: the 'gender paradox'.
European heart journal 2003;24(24):2239.
2003: Andrew D Blann; Sunil Nadar; Gregory Y H Lip
The adhesion molecule P-selectin and cardiovascular disease.
European heart journal 2003;24(24):2166-79.
2003: Vanessa Roldán; Francisco Marín; Gregory Y H Lip; Andrew D Blann
Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.
Thrombosis and haemostasis 2003;90(6):1007-20.
2003: Muzahir H Tayebjee; Gregory Y H Lip
Psychosocial functioning of adults with congenital heart disease: a neglected area.
European heart journal 2003;24(23):2159; author reply 2159-60.
2003: Deirdre Lane; Douglas Carroll; Gregory Y H Lip
Anxiety, depression, and prognosis after myocardial infarction: is there a causal association?
Journal of the American College of Cardiology 2003;42(10):1808-10.
2003: Kiat T Tan; Gregory Y H Lip
Red vs white thrombi: treating the right clot is crucial.
Archives of internal medicine 2003;163(20):2534-5; author reply 2535.
2003: Kiat T Tan; Gregory Y H Lip
Platelets, atherosclerosis and the endothelium: new therapeutic targets?
Expert opinion on investigational drugs 2003;12(11):1765-76.
2003: Kaeng W Lee; Gregory Y H Lip
Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review.
Archives of internal medicine 2003;163(19):2368-92.
2003: Aun Yeong Chong; Gregory Y H Lip
LIFE: losartan versus atenolol.
Lancet 2003;362(9393):1416.
2003: Graham J Caine; Paul S Stonelake; Daniel Rea; Gregory Y H Lip
Coagulopathic complications in breast cancer.
Cancer 2003;98(8):1578-86.
2003: Graham J Caine; Gregory Y H Lip
Thromboembolism associated with new anti-cancer treatment strategies in combination with conventional chemotherapy: new drugs, old risks?
Thrombosis and haemostasis 2003;90(4):567-9.
2003: Bernard S P Chin; Christopher R Gibbs; Andrew D Blann; Gregory Y H Lip
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Clinical science (London, England : 1979) 2003;105(4):507-12.
2003: Kate Jolly; Gregory Y H Lip; Josie Sandercock; Sheila M Greenfield; James Raftery; Jonathan Mant; Rod S Taylor; Deirdre Lane; Kaeng Wai Lee; Andrew J Stevens
Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263].
BMC cardiovascular disorders 2003;3():10.
2003: Irene Chung; Gregory Y H Lip
Virchow's triad revisited: blood constituents.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):449-54.
2003: Anirban Choudhury; Gregory Y H Lip
Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):282-9.
2003: Sunil Nadar; Gregory Y H Lip; D Gareth Beevers
Primary hyperaldosteronism.
Annals of clinical biochemistry 2003;40(Pt 5):439-52.
2003: Bernard S P Chin; Dwayne S G Conway; Natali A Y Chung; Andrew D Blann; Christopher R Gibbs; Gregory Y H Lip
Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):515-21.
2003: Sunil Nadar; Gregory Y H Lip
Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role.
Stroke; a journal of cerebral circulation 2003;34(9):e143; author reply e143-5.
2003: Jonathan Mant; Suzanne H Richards; F D Richard Hobbs; David Fitzmaurice; Gregory Y H Lip; Ellen Murray; Miriam Banting; Kate Fletcher; Joy Rahman; Teresa F Allan; James Raftery; Stirling Bryan
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
BMC cardiovascular disorders 2003;3():9.
2003: Dirk C Felmeden; Charles G C Spencer; Natali A Y Chung; Funmi M Belgore; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
The American journal of cardiology 2003;92(4):400-5.
2003: Aun Yeong Chong; Ratna Rajaratnam; Nur Run Hussein; Gregory Y H Lip
Heart failure in a multiethnic population in Kuala Lumpur, Malaysia.
European journal of heart failure 2003;5(4):569-74.
2003: Vanessa Roldán; Francisco Marin; Andrew D Blann; Amaya García; Pascual Marco; Francisco Sogorb; Gregory Y H Lip
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.
European heart journal 2003;24(14):1373-80.
2003: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):513-4.
2003: Muzahir H Tayebjee; Gregory Y H Lip
Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus?
The American journal of cardiology 2003;92(1):47-9.
2003: Dwayne S G Conway; Lesly A Pearce; Bernard S P Chin; Robert Hart; Gregory Y H Lip
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
Circulation 2003;107(25):3141-5.
2003: Kiat T Tan; Gregory Y H Lip; Andrew D Blann
Post-stroke inflammatory response: effects of stroke evolution and outcome.
Current atherosclerosis reports 2003;5(4):245-51.
2003: Andrew D Blann; Sunil Nadar; Gregory Y H Lip
Pharmacological modulation of platelet function in hypertension.
Hypertension 2003;42(1):1-7.
2003: Hoong Sern Lim; Gregory Y H Lip
Diabetes, the renin-angiotensin system and heart disease.
Current vascular pharmacology 2003;1(2):225-38.
2003: Andrew D Blann; Gregory Y H Lip
Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):335-40.
2003: Graham J Caine; Gregory Y H Lip
Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
Archives of internal medicine 2003;163(10):1243-4; author reply 1244.
2003: Sunil Nadar; Gregory Y H Lip
Hypertension and the prothrombotic state.
Journal of the American College of Cardiology 2003;41(10):1847; author reply 1847.
2003: Graham J Caine; Gregory Y H Lip
Validity of D-dimer tests for pulmonary embolism: better to diagnose or exclude?
Annals of emergency medicine 2003;41(5):756; author reply 756-7.
2003: Ali Hamaad; Gregory Y H Lip
Intravenous water-soluble amiodarone improved 24-hour survival in incessant ventricular tachycardia.
ACP journal club 2003;138(3):62.
2003: Sunil Nadar; Hoong Sern Lim; Gregory Y H Lip
Implications of the LIFE trial.
Expert opinion on investigational drugs 2003;12(5):871-7.
2003: Ali Hamaad; Muzahir H Tayebjee; Gregory Y H Lip
The METHRO trials.
Expert opinion on investigational drugs 2003;12(5):865-70.
2003: Kiat T Tan; Andrew Makin; Gregory Y H Lip
Factor X inhibitors.
Expert opinion on investigational drugs 2003;12(5):799-804.
2003: Francisco Marin; Vanessa Roldán; Vicente Climent; Amaya Garcia; Pascual Marco; Gregory Y H Lip
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Stroke; a journal of cerebral circulation 2003;34(5):1181-6.
2003: Sunil Nadar; Nazneen Begum; Bhupinder Kaur; Sukhpreet Sandhu; Gregory Y H Lip
Patients' understanding of anticoagulant therapy in a multiethnic population.
Journal of the Royal Society of Medicine 2003;96(4):175-9.
2003: Andrew J Makin; Natali A Y Chung; Stanley H Silverman; Gregory Y H Lip
Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
Clinical science (London, England : 1979) 2003;104(4):397-404.
2003: Francisco Marin; Vanessa Roldán; Gregory Y H Lip
Fibrinolytic function and atrial fibrillation.
Thrombosis research 2003;109(5-6):233-40.
2003: Andrew J Makin; Natali A Y Chung; Stanley H Silverman; Mark S Moss; Gregory Y H Lip
Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease.
Pathophysiology of haemostasis and thrombosis 2003;33(2):102-8.
2003: Bernard S P Chin; Nigel J Langford; Sarah L Nuttall; Christopher R Gibbs; Andrew D Blann; Gregory Y H Lip
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
European journal of heart failure 2003;5(2):171-4.
2003: Hoong Sern Lim; Gregory Y H Lip
A case of breathlessness.
The Practitioner 2003;247(1644):199-200, 204-7.
2003: Bethan Freestone; Gregory Y H Lip
Anticoagulation uptake in emergency department patients with atrial fibrillation.
Stroke; a journal of cerebral circulation 2003;34(3):591; author reply 591.
2003: Dirk C Felmeden; Charles G C Spencer; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
Hypertension 2003;41(3):528-33.
2003: Dwayne S G Conway; Jan Heeringa; Deirdre A M van der Kuip; Bernard S P Chin; Albert Hofman; Jacqueline C M Witteman; Gregory Y H Lip
Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.
Stroke; a journal of cerebral circulation 2003;34(2):413-7.
2003: Gregory Y H Lip
Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited.
Hypertension 2003;41(2):199-200.
2003: Gregory Y H Lip; D Gareth Beevers
Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension--does it matter? (no!).
Journal of cardiovascular risk 2003;10(1):11-4.
2003: Graham J Caine; Gregory Y H Lip
D-dimer tests for assessment of patients with suspected pulmonary embolism.
Archives of internal medicine 2003;163(2):243.
2003: Andrew D Blann; David A Fitzmaurice; Gregory Y H Lip
Anticoagulation in hospitals and general practice.
BMJ (Clinical research ed.) 2003;326(7381):153-6.
2003: Graham J Caine; Andrew D Blann; Paul S Stonelake; Sean T Kehoe; Gregory Y H Lip
Tamoxifen for breast-cancer prevention.
Lancet 2003;361(9352):177-8; author reply 178.
2003: Bernd Jilma; Sridhar Kamath; Gregory Y H Lip
ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions.
BMJ (Clinical research ed.) 2003;326(7380):93-6.
2003: Bernd Jilma; Sridhar Kamath; Gregory Y H Lip
Antithrombotic therapy in special circumstances. I--pregnancy and cancer.
BMJ (Clinical research ed.) 2003;326(7379):37-40.
2003: Ali Hamaad; Gregory Y H Lip; Robert J MacFadyen
Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology?
Annals of medicine 2003;35(8):592-604.
2003: Andrew J Makin; Natali A Y Chung; Stanley H Silverman; Gregory Y H Lip
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.
Thrombosis research 2003;111(4-5):221-6.
2003: Gregory Y H Lip
The prothrombotic state in atrial fibrillation: the atrium, the endothelium... And tissue factor?
Thrombosis research 2003;111(3):133-5.
2003: Sunil Nadar; Gregory Y H Lip
The prothrombotic state in hypertension and the effects of antihypertensive treatment.
Current pharmaceutical design 2003;9(21):1715-32.
2003: Robert J MacFadyen; Gregory Y H Lip; Russell Davis
Hypertension to heart failure: new developmental strategies do not cross a clinical and therapeutic divide.
Current pharmaceutical design 2003;9(21):1665-78.
2003: Bethan Freestone; Gregory Y H Lip
Ethnicity and arrhythmias.
Cardiac electrophysiology review 2003;7(1):92-5.
2003: Staffan Svensson; Gregory Y H Lip
Patient perceptions of hypertension and its treatment.
Blood pressure 2003;12(1):5-6.
2003: Dirk C Felmeden; Charles G C Spencer; Funmi M Belgore; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
American journal of hypertension 2003;16(1):11-20.
2002: Thomas Meinertz; Gregory Y H Lip; Fedrico Lombardi; Zigmunt P Sadowski; Brigitte Kalsch; Anne Camez; Ann C Hewkin; Siegfried Eberle
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
The American journal of cardiology 2002;90(12):1300-6.
2002: Derek L Connolly; Gregory Y H Lip; Bernard S P Chin
Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions.
BMJ (Clinical research ed.) 2002;325(7377):1404-7.
2002: Robert D S Watson; Bernard S P Chin; Gregory Y H Lip
Antithrombotic therapy in acute coronary syndromes.
BMJ (Clinical research ed.) 2002;325(7376):1348-51.
2002: Deirdre Lane; Douglas Carroll; Christopher Ring; D Gareth Beevers; Gregory Y H Lip
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction.
International journal of epidemiology 2002;31(6):1179-82.
2002: Bernard S P Chin; Natali A Y Chung; Christopher R Gibbs; Andrew D Blann; Gregory Y H Lip
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.
The American journal of cardiology 2002;90(11):1258-60.
2002: Gregory Y H Lip; Bernard S P Chin; Neeraj Prasad
ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina.
BMJ (Clinical research ed.) 2002;325(7375):1287-9.
2002: Ira R A Goldsmith; Alexander G G Turpie; Gregory Y H Lip
Valvar heart disease and prosthetic heart valves.
BMJ (Clinical research ed.) 2002;325(7374):1228-31.
2002: Gregory Y H Lip; Sridhar Kamath; Robert Hart
ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders.
BMJ (Clinical research ed.) 2002;325(7373):1161-3.
2002: Andrew J Makin; Stanley H Silverman; Gregory Y H Lip
Antithrombotic therapy in peripheral vascular disease.
BMJ (Clinical research ed.) 2002;325(7372):1101-4.
2002: Gregory Y H Lip; Robert Hart; Dwayne S G Conway
Antithrombotic therapy for atrial fibrillation.
BMJ (Clinical research ed.) 2002;325(7371):1022-5.
2002: Sunil Nadar; Gregory Y H Lip
Ongoing trials involving angiotensin-converting enzyme inhibitors.
Expert opinion on investigational drugs 2002;11(11):1633-43.
2002: Sridar Kamath; Gregory Y H Lip
Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.
The American journal of geriatric cardiology 2002;11(6):357-62; quiz 363-4.
2002: Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
The hypercoagulable state of malignancy: pathogenesis and current debate.
Neoplasia (New York, N.Y.) 2002;4(6):465-73.
2002: Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Hypertension, left ventricular hypertrophy, and sudden death.
Current cardiology reports 2002;4(6):449-57.
2002: Alexander G G Turpie; Bernard S P Chin; Gregory Y H Lip
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies.
BMJ (Clinical research ed.) 2002;325(7370):948-50.
2002: Alexander G G Turpie; Bernard S P Chin; Gregory Y H Lip
Venous thromboembolism: pathophysiology, clinical features, and prevention.
BMJ (Clinical research ed.) 2002;325(7369):887-90.
2002: David A Fitzmaurice; Andrew D Blann; Gregory Y H Lip
Bleeding risks of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7368):828-31.
2002: Dwayne S G Conway; Lesly A Pearce; Bernard S P Chin; Robert Hart; Gregory Y H Lip
Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
Circulation 2002;106(15):1962-7.
2002: Andrew D Blann; Martin J Landray; Gregory Y H Lip
ABC of antithrombotic therapy: An overview of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7367):762-5.
2002: Graham J Caine; Gregory Y H Lip
Anticoagulants as anticancer agents?
The lancet oncology 2002;3(10):591-2.
2002: Natali A Y Chung; Funmi M Belgore; Foo Leong Li-Saw-Hee; Dwayne S G Conway; Andrew D Blann; Gregory Y H Lip
Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?
Stroke; a journal of cerebral circulation 2002;33(9):2187-91.
2002: Andrew D Blann; Paul M Ridker; Gregory Y H Lip
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
Stroke; a journal of cerebral circulation 2002;33(9):2141-3.
2002: Andrew D Blann; Charles N McCollum; Gregory Y H Lip
Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(6):513-8.
2002: Sridhar Kamath; Andrew D Blann; Bernard S P Chin; Gregory Y H Lip
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Journal of the American College of Cardiology 2002;40(3):484-90.
2002: Kaeng W Lee; Gregory Y H Lip
Airborne occupational exposure and ABO phenotype: an example of gene-environment interaction in ischaemic heart disease?
Journal of cardiovascular risk 2002;9(4):179-82.
2002: Andrew J Makin; Natali A Y Chung; Stanley H Silverman; Gregory Y H Lip
Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease.
Pathophysiology of haemostasis and thrombosis 2002;32(4):158-64.
2002: Sunil Nadar; D Gareth Beevers; Gregory Y H Lip
Hypertension and renal failure.
Clinical medicine (London, England) 2002;2(4):378-9.
2002: Charles G C Spencer; David Gurney; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Hypertension 2002;40(1):61-6.
2002: David Gurney; Gregory Y H Lip; Andrew D Blann
A reliable plasma marker of platelet activation: does it exist?
American journal of hematology 2002;70(2):139-44.
2002: Sunil Nadar; Gregory Y H Lip
Cardiomyopathy in practice.
The Practitioner 2002;246(1635):416, 420-7.
2002: Pascual Marco; Francisco Marin; Amaya García; Vanessa Roldán; Gregory Y H Lip
Do protein Z levels influence the prothrombotic state in atrial fibrillation?
Thrombosis research 2002;106(4-5):269-70.
2002: Sridhar Kamath; Andrew D Blann; Graham J Caine; David Gurney; Bernard S P Chin; Gregory Y H Lip
Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Stroke; a journal of cerebral circulation 2002;33(5):1237-42.
2002: Bethan Freestone; Gregory Y H Lip
Prevalence and risk factors of silent brain infarcts in the population.
Stroke; a journal of cerebral circulation 2002;33(5):1179-80; author reply 1179-80.
2002: Kaeng W Lee; Dirk C Felmeden; Gregory Y H Lip
Statins and the assessment of endothelial function.
Journal of internal medicine 2002;251(5):452-3; author reply 453-4.
2002: Bethan Freestone; Gregory Y H Lip
Risk factors for mortality in acute myocardial infarction.
Lancet 2002;359(9313):1252.
2002: Kaeng W Lee; Dirk C Felmeden; Gregory Y H Lip
Lipid lowering and the assessment of endothelial function.
Cardiovascular research 2002;54(1):191-2; author reply 193-4.
2002: Kenneth M A MacMahon; Gregory Y H Lip
Psychological factors in heart failure: a review of the literature.
Archives of internal medicine 2002;162(5):509-16.
2002: Andrew D Blann; Gregory Y H Lip
Soluble adhesion molecules and coronary heart disease.
Lancet 2002;359(9305):525-6; author reply 526-7.
2002: Andrew D Blann; Funmi M Belgore; Charles N McCollum; Stanley Silverman; Peck Lin Lip; Gregory Y H Lip
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
Clinical science (London, England : 1979) 2002;102(2):187-94.
2002: Aun Yeong Chong; Gregory Y H Lip
Hormone replacement therapy and cardiovascular risk.
Treatments in endocrinology 2002;1(2):95-103.
2002: Bethan Freestone; Gregory Y H Lip
Antiarrhythmics in atrial fibrillation.
Current opinion in investigational drugs (London, England : 2000) 2002;3(1):84-8.
2002: Gregory Y H Lip; Bernard S P Chin; Andrew D Blann
Cancer and the prothrombotic state.
The lancet oncology 2002;3(1):27-34.
2002: Gregory Y H Lip; Sridhar Kamath; Marian Jafri; Afzal Mohammed; David Bareford
Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project.
Stroke; a journal of cerebral circulation 2002;33(1):238-42.
2001: T S Dhanjal; M Lal; R Haynes; Gregory Y H Lip
A comparison of cardiovascular risk factors among Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England.
International journal of clinical practice 2001;55(10):665-8.
2001: D Gareth Beevers; Gregory Y H Lip
The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy.
Journal of human hypertension 2001;15(12):837-9.
2001: Gregory Y H Lip; D Gareth Beevers
ACE inhibitors in vascular disease: some PROGRESS, more HOPE.
Journal of human hypertension 2001;15(12):833-5.
2001: Gregory Y H Lip; F L Hee
Paroxysmal atrial fibrillation.
QJM : monthly journal of the Association of Physicians 2001;94(12):665-78.
2001: Sridhar Kamath; Andrew D Blann; Gregory Y H Lip
Platelets and atrial fibrillation.
European heart journal 2001;22(24):2233-42.
2001: CR Gibbs; Andrew D Blann; E Edmunds; RD Watson; Gregory Y H Lip
Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
Clinical cardiology 2001;24(11):724-9.
2001: C M Langman; Antonia C Lyons; Gregory Y H Lip
Perceptions and behaviour of hypertensive patients: a divine intervention or a case for Hippocrates?
Journal of human hypertension 2001;15(11):751-4.
2001: Dirk C Felmeden; Gregory Y H Lip; Gareth D Beevers
Calcium antagonists in diabetic hypertension.
Diabetes, obesity & metabolism 2001;3(5):311-8.
2001: Bernard S P Chin; K Futaba; A Jethwa; Gregory Y H Lip
The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
International journal of clinical practice 2001;55(8):515-8.
2001: Gregory Y H Lip
Alcohol and the heart.
The Practitioner 2001;245(1627):808-10, 812, 814 passim.
2001: Deirdre Lane; Douglas Carroll; Christopher Ring; D G Beevers; Gregory Y H Lip
Predictors of attendance at cardiac rehabilitation after myocardial infarction.
Journal of psychosomatic research 2001;51(3):497-501.
2001: Andrew D Blann; F Lanza; P Galajda; D Gurney; S Moog; J P Cazenave; Gregory Y H Lip
Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking.
Thrombosis and haemostasis 2001;86(3):777-83.
2001: Charles G C Spencer; Gregory Y H Lip
Left internal mammary graft stenosis and restenosis following angioplasty and stenting.
Heart (British Cardiac Society) 2001;86(3):E9.
2001: Foo Leong Li-Saw-Hee; Andrew D Blann; D Gurney; Gregory Y H Lip
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
European heart journal 2001;22(18):1741-7.
2001: Sridhar Kamath; Andrew D Blann; Gregory Y H Lip
Platelet activation: assessment and quantification.
European heart journal 2001;22(17):1561-71.
2001: S Kamath; Gregory Y H Lip
YM-337. Yamanouchi.
Current opinion in investigational drugs (London, England : 2000) 2001;2(8):1093-6.
2001: Charles G C Spencer; D Gareth Beevers; Gregory Y H Lip
Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment.
Journal of human hypertension 2001;15 Suppl 1():S39-42.
2001: Gregory Y H Lip; E Edmunds; F L Hee; Andrew D Blann; D Gareth Beevers
A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
American journal of hypertension 2001;14(8 Pt 1):823-8.
2001: Bernard S P Chin; Gregory Y H Lip
New pharmacological strategies for the treatment of heart failure.
Current opinion in investigational drugs (London, England : 2000) 2001;2(7):923-8.
2001: C Lydakis; Michele Beevers; D Gareth Beevers; Gregory Y H Lip
The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
International journal of clinical practice 2001;55(6):361-7.
2001: Gregory Y H Lip; E Edmunds; SC Martin; Alan F Jones; Andrew D Blann; D Gareth Beevers
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage.
American journal of hypertension 2001;14(7 Pt 1):627-31.
2001: Andrew J Makin; Gregory Y H Lip; S Silverman; D Gareth Beevers
Peripheral vascular disease and hypertension: a forgotten association?
Journal of human hypertension 2001;15(7):447-54.
2001: Natali A Y Chung; Gregory Y H Lip
Right atrial function in hypertension.
Journal of human hypertension 2001;15(7):439-41.
2001: Deirdre Lane; Gregory Y H Lip
Ethnic differences in hypertension and blood pressure control in the UK.
QJM : monthly journal of the Association of Physicians 2001;94(7):391-6.
2001: Andrew D Blann; David Gurney; Elizabeth Hughes; P Buggins; S H Silverman; Gregory Y H Lip
Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease.
The American journal of cardiology 2001;88(1):A7-8, 89-92.
2001: Gregory Y H Lip; Andrew D Blann; I S Farooqi; J Zarifis; G Sagar; D Gareth Beevers
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):307-15.
2001: B Chin; Charles G C Spencer; Gregory Y H Lip
Unstable angina following acute MI in a patient with bilateral coronary artery fistulae: an unusual presentation of coronary steal?
International journal of clinical practice 2001;55(5):342-3.
2001: Gregory Y H Lip; Michele Beevers; D Gareth Beevers; M J Dillon
The measurement of blood pressure and the detection of hypertension in children and adolescents.
Journal of human hypertension 2001;15(6):419-23.
2001: E Edmunds; Martin J Landray; Foo Leong Li-Saw-Hee; Beverly A Hughes; D Gareth Beevers; Gregory Y H Lip
Dyslipidaemia in patients with malignant-phase hypertension.
QJM : monthly journal of the Association of Physicians 2001;94(6):327-32.
2001: Dirk C Felmeden; Gregory Y H Lip
Resistant hypertension and the Birmingham Hypertension Square.
Current hypertension reports 2001;3(3):203-8.
2001: Andrew D Blann; Funmi M Belgore; Joël Constans; Claude Conri; Gregory Y H Lip
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.
The American journal of cardiology 2001;87(10):1160-3.
2001: Foo Leong Li-Saw-Hee; D Gareth Beevers; Gregory Y H Lip
Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
International journal of cardiology 2001;78(3):241-6.
2001: D Conway; Gregory Y H Lip
Case book: palpitations.
The Practitioner 2001;245(1622):393-6, 398, 401.
2001: Foo Leong Li-Saw-Hee; Andrew D Blann; E Edmunds; CR Gibbs; Gregory Y H Lip
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Clinical cardiology 2001;24(5):409-14.
2001: Funmi M Belgore; Andrew D Blann; Gregory Y H Lip
Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
Clinical science (London, England : 1979) 2001;100(5):567-75.
2001: CR Gibbs; Andrew D Blann; RD Watson; Gregory Y H Lip
Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Circulation 2001;103(13):1746-51.
2001: Dwayne S G Conway; Gregory Y H Lip
Helicobacter pylori as the cause of coronary artery restenosis following angioplasty--is the way to a man's heart disease through his stomach?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(3):214-6.
2001: D Conway; Gregory Y H Lip
The ECG and left ventricular hypertrophy in primary care hypertensives.
Journal of human hypertension 2001;15(4):215-7.
2001: PL Lip; Andrew D Blann; MW Hope-Ross; JM Gibson; Gregory Y H Lip
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
Ophthalmology 2001;108(4):705-10.
2001: Funmi M Belgore; Andrew D Blann; Foo Leong Li-Saw-Hee; D Gareth Beevers; Gregory Y H Lip
Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension.
The American journal of cardiology 2001;87(6):805-7, A9.
2001: Gregory Y H Lip; E Edmunds; D Gareth Beevers
Should patients with hypertension receive antithrombotic therapy?
Journal of internal medicine 2001;249(3):205-14.
2001: Bernard S P Chin; Gregory Y H Lip
Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
Journal of human hypertension 2001;15(2):89-92.
2001: Gregory Y H Lip; D Gareth Beevers
Calcium channel blockers in hypertension: the debate reawakens.
Journal of human hypertension 2001;15(2):85-7.
2001: Gregory Y H Lip; Christopher R Gibbs
Anticoagulation for heart failure in sinus rhythm.
Cochrane database of systematic reviews (Online) 2001;(4):CD003336.
2001: Gregory Y H Lip; Christopher R Gibbs
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
Cochrane database of systematic reviews (Online) 2001;(4):CD003333.
2001: Dwayne S G Conway; Gregory Y H Lip
New antiarrhythmic agents for atrial fibrillation.
Current opinion in investigational drugs (London, England : 2000) 2001;2(1):87-92.
2001: Funmi M Belgore; Gregory Y H Lip; David Bareford; M Wadley; Paul S Stonelake; Andrew D Blann
Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
American journal of hematology 2001;66(1):59-61.
2001: Andrew D Blann; D Gurney; M Wadley; David Bareford; Paul S Stonelake; Gregory Y H Lip
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(1):43-50.
2001: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
The American journal of cardiology 2001;87(1):107-10, A9.
2000: B Chin; Gregory Y H Lip
Cariporide Aventis.
Current opinion in investigational drugs (London, England : 2000) 2000;1(3):340-6.
2000: Deirdre Lane; D Carroll; C Ring; D Gareth Beevers; Gregory Y H Lip
Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?
QJM : monthly journal of the Association of Physicians 2000;93(11):739-44.
2000: Ira R A Goldsmith; P Kumar; P Carter; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
American heart journal 2000;140(5):777-84.
2000: Dirk C Felmeden; Gregory Y H Lip
Myocardial bridging.
International journal of clinical practice 2000;54(8):542-3.
2000: Deirdre Lane; Douglas Carroll; Christopher Ring; D G Beevers; Gregory Y H Lip
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction.
Journal of psychosomatic research 2000;49(4):229-38.
2000: Gregory Y H Lip
Hypertension and the prothrombotic state.
Journal of human hypertension 2000;14(10-11):687-90.
2000: Gregory Y H Lip; C Lydakis; S L Nuttall; Martin J Landray; Robert D Watson; Andrew D Blann
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Journal of internal medicine 2000;248(4):316-8.
2000: Gregory Y H Lip; Dirk C Felmeden; Foo Leong Li-Saw-Hee; D Gareth Beevers
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
European heart journal 2000;21(20):1653-65.
2000: Foo Leong Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation.
The American journal of cardiology 2000;86(7):795-7, A9.
2000: M K Steiner; P B Clarkson; Gregory Y H Lip
Myocardial infarction complicating hormone replacement therapy in a young woman with normal coronary arteries.
International journal of clinical practice 2000;54(7):475-7.
2000: Andrew D Blann; J Amiral; Charles N McCollum; Gregory Y H Lip
Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.
Atherosclerosis 2000;152(1):29-34.
2000: Foo Leong Li-Saw-Hee; E Edmunds; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
International journal of cardiology 2000;75(1):43-7.
2000: Gregory Y H Lip; Michele Beevers; D Gareth Beevers
Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs?
American journal of hypertension 2000;13(8):934-9.
2000: Ira R A Goldsmith; L S Foo; Andrew D Blann; Gregory Y H Lip
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Clinical cardiology 2000;23(8):587-90.
2000: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation.
The American journal of cardiology 2000;86(2):234-6.
2000: Dirk C Felmeden; S P Singh; Gregory Y H Lip
Anomalous coronary arteries of aortic origin.
International journal of clinical practice 2000;54(6):390-4.
2000: PL Lip; Funmi M Belgore; Andrew D Blann; MW Hope-Ross; JM Gibson; Gregory Y H Lip
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Investigative ophthalmology & visual science 2000;41(8):2115-9.
2000: S Kamath; Gregory Y H Lip
Managing cardiac arrhythmias. Part II. Management strategies for specific cardiac arrhythmias.
The Practitioner 2000;244(1611):568-73.
2000: S Kamath; Gregory Y H Lip
Managing cardiac arrhythmias. Part I. General principles of investigation and management.
The Practitioner 2000;244(1611):559, 560, 563-5.
2000: Foo Leong Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
Journal of the American College of Cardiology 2000;35(7):1926-31.
2000: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
The American journal of cardiology 2000;85(10):1218-22.
2000: C G Spencer; Gregory Y H Lip
Haemorheological factors in hypertension.
Journal of human hypertension 2000;14(5):291-3.
2000: D Gareth Beevers; Gregory Y H Lip
Do alpha blockers cause heart failure and stroke? Observations from ALLHAT.
Journal of human hypertension 2000;14(5):287-9.
2000: CR Gibbs; Gregory Y H Lip
Takayasu's pulseless disease.
Clinical cardiology 2000;23(4):293-4.
2000: Foo Leong Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Stroke; a journal of cerebral circulation 2000;31(4):828-33.
2000: E Edmunds; D Gareth Beevers; Gregory Y H Lip
What has happened to malignant hypertension? A disease no longer vanishing.
Journal of human hypertension 2000;14(3):159-61.
2000: CR Gibbs; G Jackson; Gregory Y H Lip
ABC of heart failure. Non-drug management.
BMJ (Clinical research ed.) 2000;320(7231):366-9.
2000: CR Gibbs; Gregory Y H Lip; D Gareth Beevers
Salt and cardiovascular disease: clinical and epidemiological evidence.
Journal of cardiovascular risk 2000;7(1):9-13.
2000: RD Watson; CR Gibbs; Gregory Y H Lip
ABC of heart failure. Clinical features and complications.
BMJ (Clinical research ed.) 2000;320(7229):236-9.
2000: Dirk C Felmeden; Gregory Y H Lip; Michele Beevers; D Gareth Beevers
The placebo effect and white coat effect in isolated systolic hypertension and systo-diastolic hypertension.
Blood pressure 2000;9(6):335-9.
2000: Dirk C Felmeden; Gregory Y H Lip
Hormone replacement therapy and hypertension.
Blood pressure 2000;9(5):246-9.
2000: Funmi M Belgore; Gregory Y H Lip; Andrew D Blann
Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
British journal of biomedical science 2000;57(3):207-13.
2000: E Edmunds; Gregory Y H Lip
An independent verdict: does infection with Helicobacter pylori cause ischaemic heart disease?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(1):69-70.
2000: Gregory Y H Lip; Michele Beevers; D Gareth Beevers
Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension.
Journal of hypertension 2000;18(1):97-101.
2000: Russell C Davis; F D Richard Hobbs; Gregory Y H Lip
ABC of heart failure. History and epidemiology.
BMJ (Clinical research ed.) 2000;320(7226):39-42.
1999: Charles G C Spencer; Gregory Y H Lip; D Gareth Beevers
Recurrent malignant hypertension: a report of two cases and review of the literature.
Journal of internal medicine 1999;246(5):513-6.
1999: A D Blann; F Li-Saw-Hee; Gregory Y H Lip; Tetsuo Minamino; Masafumi Kitakaze; Shoji Sanada; Hiroshi Asanuma; Toshiya Kurotobi; Yukihiro Koretsune; Masatake Fukunami; Tsunehiko Kuzuya; Noritake Hoki; Masatsugu Hori
Increased membrane and soluble P-selectin in atrial fibrillation.
Circulation 1999;100(17):e86-7.
1999: Gregory Y H Lip
Atrial fibrillation in general practice.
The Practitioner 1999;243(1603):746-51.
1999: Deirdre Lane; D Carroll; Gregory Y H Lip
Psychology in coronary care.
QJM : monthly journal of the Association of Physicians 1999;92(8):425-31.
1999: Gregory Y H Lip; Andrew D Blann; D Gareth Beevers
Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension.
Journal of hypertension 1999;17(8):1203-7.
1999: Gregory Y H Lip
Antihypertensive agents and left ventricular hypertrophy with 'usual' care in the population setting.
Journal of human hypertension 1999;13(8):497-8.
1999: Andrew D Blann; P Kumar; J Krupinski; C McCollum; D Gareth Beevers; Gregory Y H Lip
Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(5):277-84.
1999: Gregory Y H Lip; M Douglas; A Gupta; D Gareth Beevers
Urinary sodium excretion and blood pressure in chronic psychiatric in-patients.
Journal of human hypertension 1999;13(7):461-6.
1999: Gregory Y H Lip; R E Ferner
Diuretic therapy for hypertension: a cancer risk?
Journal of human hypertension 1999;13(7):421-3.
1999: C Lydakis; Gregory Y H Lip; Michele Beevers; D Gareth Beevers
Atenolol and fetal growth in pregnancies complicated by hypertension.
American journal of hypertension 1999;12(6):541-7.
1999: Foo Leong Li-Saw-Hee; Andrew D Blann; I Goldsmith; Gregory Y H Lip
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
The American journal of cardiology 1999;83(8):1206-9.
1999: CR Gibbs; D Gareth Beevers; Gregory Y H Lip
The management of hypertensive disease in black patients.
QJM : monthly journal of the Association of Physicians 1999;92(4):187-92.
1999: Gregory Y H Lip; CR Gibbs
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
Journal of the American College of Cardiology 1999;33(5):1424-6.
1999: Foo Leong Li-Saw-Hee; Gregory Y H Lip
Atrial fibrillation, thromboembolism and antithrombotic therapy.
International journal of clinical practice 1999;53(2):110-7.
1999: Gregory Y H Lip
Thromboprophylaxis for atrial fibrillation.
Lancet 1999;353(9146):4-6.
1999: Martin J Landray; G Sagar; S Murray; M Beevers; D Gareth Beevers; Gregory Y H Lip
White coat hypertension and carotid atherosclerosis.
Blood pressure 1999;8(3):134-40.
1999: Martin J Landray; Gregory Y H Lip
White coat hypertension: a recognised syndrome with uncertain implications.
Journal of human hypertension 1999;13(1):5-8.
1998: C Lydakis; D Gareth Beevers; Michele Beevers; Gregory Y H Lip
Obstetric and neonatal outcome following chronic hypertension in pregnancy among different ethnic groups.
QJM : monthly journal of the Association of Physicians 1998;91(12):837-44.
1998: Gregory Y H Lip
Beta-blockers in hypertension: to reappraise or to call a halt?
Journal of human hypertension 1998;12(12):799-801.
1998: Gregory Y H Lip; Michele Beevers; D Gareth Beevers
The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension.
Journal of human hypertension 1998;12(11):761-3.
1998: PL Lip; Alan F Jones; N Price; M Headon; D Gareth Beevers; Gregory Y H Lip
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?
Acta ophthalmologica Scandinavica 1998;76(5):533-6.
1998: Martin J Landray; S L Nuttall; C Lydakis; U Martin; Simon R J Maxwell; Gregory Y H Lip
Oxidative stress after thrombolysis.
Lancet 1998;352(9132):960.
1998: C Lydakis; A Y Chaudary; Gregory Y H Lip
The 'vasovagal effect' of nitrates: an under-recognised complication of nitrate use.
International journal of clinical practice 1998;52(6):418-21.
1998: D Gareth Beevers; Gregory Y H Lip
JNC-VI: a view from the United Kingdom.
Journal of human hypertension 1998;12(9):649-51.
1998: Gregory Y H Lip; S P Singh; D G Beevers
Aortic coarctation diagnosed after hypertension in pregnancy.
American journal of obstetrics and gynecology 1998;179(3 Pt 1):814-5.
1998: Gregory Y H Lip; KK Ray; Man Fai Shiu
Coronary spasm in acute myocardial infarction.
Heart (British Cardiac Society) 1998;80(2):197-9.
1998: Andrew D Blann; Gregory Y H Lip
Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(8):634-42.
1998: Gregory Y H Lip; L Bawden; R Hodson; E Rutland; J Snatchfold; D Gareth Beevers
Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project.
International journal of cardiology 1998;65(2):187-92.
1998: Gregory Y H Lip; C Lydakis; J Zarifis; F H Messerli
Regression of LVH or improved prognosis (or both): what is the question?
Journal of human hypertension 1998;12(7):423-5.
1998: C Lydakis; Gregory Y H Lip
Microalbuminuria and cardiovascular risk.
QJM : monthly journal of the Association of Physicians 1998;91(6):381-91.
1998: Andrew D Blann; Gregory Y H Lip
The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(4):297-306.
1998: Martin J Landray; G Sagar; J Muskin; S Murray; Roger L Holder; Gregory Y H Lip
Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis.
QJM : monthly journal of the Association of Physicians 1998;91(5):345-51.
1998: Foo Leong Li-Saw-Hee; Gregory Y H Lip
Digoxin revisited.
QJM : monthly journal of the Association of Physicians 1998;91(4):259-64.
1998: CR Gibbs; Gregory Y H Lip
Do we still need dipyridamole?
British journal of clinical pharmacology 1998;45(4):323-8.
1998: CR Gibbs; Foo Leong Li-Saw-Hee; Gregory Y H Lip
Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
Scottish medical journal 1998;43(1):6.
1998: PL Lip; Andrew D Blann; Alan F Jones; Gregory Y H Lip
Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Eye (London, England) 1998;12 ( Pt 2)():245-51.
1998: C Lydakis; H Kerr; K Hutchings; Gregory Y H Lip
Women's awareness of, and attitudes towards, hormone replacement therapy: ethnic differences and effects of age and education.
International journal of clinical practice 1998;52(1):7-12.
1997: Gregory Y H Lip; Andrew D Blann; Alan F Jones; PL Lip; D Gareth Beevers
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
The American journal of cardiology 1997;80(12):1566-71.
1997: Gregory Y H Lip; D Gareth Beevers
'Reverse dipping' on ambulatory blood pressure monitoring.
Journal of human hypertension 1997;11(12):821-2.
1997: Andrew D Blann; Gregory Y H Lip
Platelets and hypertension: the pressure is on the clot.
Journal of human hypertension 1997;11(12):763-4.
1997: Gregory Y H Lip; D Churchill; Michele Beevers; A Auckett; D Gareth Beevers
Angiotensin-converting-enzyme inhibitors in early pregnancy.
Lancet 1997;350(9089):1446-7.
1997: C Lydakis; K Hollinrake; Gregory Y H Lip
An unusual cause of palpitations requiring atrioventricular node ablation and pacemaker therapy.
Blood pressure 1997;6(6):368-71.
1997: C Lydakis; A Efstratopoulos; Gregory Y H Lip
Microalbuminuria in hypertension: is it up to measure?
Journal of human hypertension 1997;11(11):695-7.
1997: Gregory Y H Lip
Atrial fibrillation in hypertension: under recognised or over diagnosed?
Journal of human hypertension 1997;11(11):691-3.
1997: Gregory Y H Lip; Michele Beevers; D Gareth Beevers
Does renal function improve after diagnosis of malignant phase hypertension?
Journal of hypertension 1997;15(11):1309-15.
1997: Dirk C Felmeden; Gregory Y H Lip; D Gareth Beevers
Fibromuscular dysplasia.
Journal of human hypertension 1997;11(10):687-8.
1997: Gregory Y H Lip; Andrew D Blann; Alan F Jones; D Gareth Beevers
Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
American heart journal 1997;134(4):764-71.
1997: F L Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
The detection of endothelial dysfunction in patients with essential hypertension.
International journal of cardiology 1997;61(2):171-4.
1997: Gregory Y H Lip; Michele Beevers; D Gareth Beevers
Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception.
QJM : monthly journal of the Association of Physicians 1997;90(9):571-5.
1997: Gregory Y H Lip; D Gareth Beevers
Can we treat coronary artery disease with antibiotics?
Lancet 1997;350(9075):378-9.
1997: Gregory Y H Lip
Can we treat hypertensive menopausal women with hormone replacement therapy?
Journal of human hypertension 1997;11(7):397-9.
1997: Gregory Y H Lip; J Zarifis; D Gareth Beevers
Acute admissions with heart failure to a district general hospital serving a multiracial population.
International journal of clinical practice 1997;51(4):223-7.
1997: D Gareth Beevers; Gregory Y H Lip
Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?
Journal of human hypertension 1997;11(6):329-30.
1997: Andrew D Blann; Gregory Y H Lip; D G Beevers; C N McCollum
Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Thrombosis and haemostasis 1997;77(6):1077-80.
1997: Gregory Y H Lip
Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk?
Lancet 1997;349(9065):1565-6.
1997: Gregory Y H Lip; Michele Beevers; D Churchill; L M Shaffer; D Gareth Beevers
Effect of atenolol on birth weight.
The American journal of cardiology 1997;79(10):1436-8.
1997: Gregory Y H Lip; Andrew D Blann
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Cardiovascular research 1997;34(2):255-65.
1997: Gregory Y H Lip
Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.
Heart (British Cardiac Society) 1997;77(5):395-6.
1997: Gregory Y H Lip
The left atrium in hypertension, an appendage often forgotten.
Journal of human hypertension 1997;11(3):145-7.
1997: J Zarifis; Gareth D Beevers; Gregory Y H Lip
Acute admissions with atrial fibrillation in a British multiracial hospital population.
The British journal of clinical practice 1997;51(2):91-6.
1997: Gregory Y H Lip; J Zarifis; I S Farooqi; A Page; G Sagar; D Gareth Beevers
Ambulatory blood pressure monitoring in acute stroke. The West Birmingham Stroke Project.
Stroke; a journal of cerebral circulation 1997;28(1):31-5.
1996: Gregory Y H Lip; O A Adeotoye; J Zarifis; S P Singh; R D Watson; D G Beevers
Ambulatory blood pressure monitoring in patients with single chamber ventricular pacemakers (VVI pacing mode)
American journal of hypertension 1996;9(12 Pt 1):1240-1.
1996: Gregory Y H Lip
Commentary: do angiotensin II receptor antagonists regress left ventricular hypertrophy?
Journal of human hypertension 1996;10(11):725-7.
1996: Gregory Y H Lip; M Z Cader; F Lee; S M Munir; D G Beevers
Ethnic differences in pre-admission levels of physical activity in patients admitted with myocardial infarction.
International journal of cardiology 1996;56(2):169-75.
1996: D G Beevers; Gregory Y H Lip
Does non-malignant essential hypertension cause renal damage? A clinician's view.
Journal of human hypertension 1996;10(10):695-9.
1996: Gregory Y H Lip; J Zarifis; Michele Beevers; D G Beevers
Ambulatory blood pressure monitoring in atrial fibrillation.
The American journal of cardiology 1996;78(3):350-3.
1996: Gregory Y H Lip; PL Lip; J Zarifis; R D Watson; D Bareford; G D Lowe; D G Beevers
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Circulation 1996;94(3):425-31.
1996: J Zarifis; Gregory Y H Lip; B Leatherdale; G Beevers
Malignant hypertension in association with primary aldosteronism.
Blood pressure 1996;5(4):250-4.
1996: Gregory Y H Lip; G Beevers; J Zarifis; S P Singh
Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. ECGs are valuable in hospital as well as general practice.
BMJ (Clinical research ed.) 1996;312(7039):1161.
1996: Gregory Y H Lip; G D Lowe
Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
British journal of clinical pharmacology 1996;41(5):369-79.
1996: Gregory Y H Lip; C Luscombe; M McCarry; I Malik; G Beevers
Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention.
Ethnicity & health 1996;1(1):47-53.
1996: Gregory Y H Lip; J Zarifis; R D Watson; D G Beevers
Physician variation in the management of patients with atrial fibrillation.
Heart (British Cardiac Society) 1996;75(2):200-5.
1996: Gregory Y H Lip; D G Beevers; J R Coope
ABC of atrial fibrillation. Atrial fibrillation in general and hospital practice.
BMJ (Clinical research ed.) 1996;312(7024):175-8.
1996: Gregory Y H Lip; R D Watson; S P Singh
ABC of atrial fibrillation. Cardioversion of atrial fibrillation.
BMJ (Clinical research ed.) 1996;312(7023):112-5.
1996: Gregory Y H Lip; G D Lowe
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
BMJ (Clinical research ed.) 1996;312(7022):45-9.
1995: Gregory Y H Lip; R D Watson; S P Singh
ABC of atrial fibrillation. Drugs for atrial fibrillation.
BMJ (Clinical research ed.) 1995;311(7020):1631-4.
1995: Gregory Y H Lip; S P Singh; R D Watson
ABC of atrial fibrillation. Investigation and non-drug management of atrial fibrillation.
BMJ (Clinical research ed.) 1995;311(7019):1562-5.
1995: Gregory Y H Lip; Andrew D Blann; J Zarifis; Michele Beevers; PL Lip; D G Beevers
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Journal of hypertension 1995;13(12 Pt 2):1674-8.
1995: Gregory Y H Lip; D G Beevers; S P Singh; R D Watson
ABC of atrial fibrillation. Aetiology, pathophysiology, and clinical features.
BMJ (Clinical research ed.) 1995;311(7017):1425-8.
1995: Gregory Y H Lip; D G Beevers
ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation.
BMJ (Clinical research ed.) 1995;311(7016):1361-3.
1995: Gregory Y H Lip
Does atrial fibrillation confer a hypercoagulable state?
Lancet 1995;346(8986):1313-4.
1995: Gregory Y H Lip; G Beevers; J Zarifis
Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint.
Journal of internal medicine 1995;238(5):389-99.
1995: Gregory Y H Lip; Michele Beevers; John Potter; D G Beevers
Malignant hypertension in the elderly.
QJM : monthly journal of the Association of Physicians 1995;88(9):641-7.
1995: Gregory Y H Lip; Michele Beevers; D G Beevers
Complications and survival of 315 patients with malignant-phase hypertension.
Journal of hypertension 1995;13(8):915-24.
1995: Gregory Y H Lip; Alan F Jones
Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis.
QJM : monthly journal of the Association of Physicians 1995;88(8):529-39.
1995: Gregory Y H Lip; I Malik; C Luscombe; M McCarry; G Beevers
Dietary fat purchasing habits in whites, blacks and Asian peoples in England--implications for heart disease prevention.
International journal of cardiology 1995;48(3):287-93.
1995: Gregory Y H Lip; Michele Beevers; D Churchill; D G Beevers
Do clinicians prescribe HRT for hypertensive postmenopausal women?
The British journal of clinical practice 1995;49(2):61-4.
1995: Gregory Y H Lip; Michele Beevers; J Zarifis; G Beevers
Seasonal variations in fatal pulmonary embolism. Malignant phase hypertension does not vary by season.
BMJ (Clinical research ed.) 1995;310(6972):129-30.
1995: Gregory Y H Lip; J Zarifis; Michele Beevers; D G Beevers
Duration of cough following cessation of ACE inhibitor therapy.
American journal of hypertension 1995;8(1):98.
1994: Gregory Y H Lip; Michele Beevers; G Beevers
The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England.
Journal of hypertension 1994;12(11):1297-305.
1994: I S Farooqi; S Dar; S Farooqi; D G Beevers; Gregory Y H Lip
A comparative study of risk factors for acute myocardial infarction amongst men of Indo-origin in Trinidad and the UK.
International journal of cardiology 1994;47(1):45-9.
1994: Gregory Y H Lip; M J Metcalfe
Have we identified the factors affecting prognosis following coronary artery bypass surgery?
The British journal of clinical practice 1994;48(6):317-22.
1994: Gregory Y H Lip; D G Beevers
Abnormalities of rheology and coagulation in hypertension.
Journal of human hypertension 1994;8(9):693-702.
1994: Gregory Y H Lip; Michele Beevers; D Churchill; D G Beevers
Hormone replacement therapy and blood pressure in hypertensive women.
Journal of human hypertension 1994;8(7):491-4.